## CLIONA ROONEY

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Nbk%2f7mvCOav3RYKj5X%2fX&rnd=30d068a4-aade-4c5d-bafa-54e89a116516)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=268355)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=268355&cachekey=23c1b105-4b5b-42f7-a16b-fba90996722f)  
  

Other Positions| Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
Title| Professor  
Institution| Baylor College of Medicine  
Department| Department of Molecular Virology & Microbiology  
Division| Molecular Virology & Microbiology  
  
  
Title| Professor  
Institution| Baylor College of Medicine  
Department| Department of Pathology & Immunology  
Division| Immunology  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

T32GM136554 (VAN DEN VEYVER, IGNATIA B)Jul 1, 2020 - Jun 30, 2025NIH  
The Clinical Translational Research Certificate of Added Qualification Program  
Role: Co-Principal Investigator  
---  
  
* * *  
  
T32GM088129 (VAN DEN VEYVER, IGNATIA B)Jul 1, 2010 - Jun 30, 2020NIH  
Training Program in Translational Biology and Molecular Medicine  
Role: Co-Principal Investigator  
  
* * *  
  
P01CA094237 (HESLOP, HELEN E)Dec 1, 2001 - Jan 31, 2020NIH  
ENHANCING T CELL THERAPY OF CANCER  
Role: Co-Principal Investigator  
  
* * *  
  
S10RR013919 (ROONEY, CLIONA M)Jun 1, 1999 - May 31, 2000NIH  
ABI PRISM 7700 SEQUENCE DETECTION SYSTEM  
Role: Principal Investigator  
  
* * *  
  
R01CA074126 (ROONEY, CLIONA M)Apr 1, 1997 - Jan 31, 2002NIH  
TREATMENT OF HODGKIN DISEASE WITH GENE MARKED CTL  
Role: Principal Investigator  
  
* * *  
  
R01CA061384 (ROONEY, CLIONA M)Sep 1, 1993 - Jan 31, 2004NIH  
CYTOTOXIC T CELL TRANSFER FOR THERAPY OF EBV LYMPHOMA  
Role: Principal Investigator  
  
* * *  
  
U01CA061384 (ROONEY, CLIONA M)Sep 1, 1993 - Dec 31, 1997NIH  
CYTOTOXIC T-CELL TRANSFER FOR THERAPY OF EBV-LYMPHOMA  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Sharma S, Mehta NU, Sauer T, [Rollins LA](https://profiles.viictr.org/profile/28998998), Dittmer DP, **Rooney CM**. Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma. Blood Adv. 2024 Jul 09; 8(13):3360-3371. PMID: [38640255](//www.ncbi.nlm.nih.gov/pubmed/38640255); PMCID: [PMC11255116](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11255116).

Citations:  Fields:

Hem Hematology

Translation:HumansAnimalsCells

  2. Kua L, Ng CH, Tan JW, Tan HC, Seh CC, Wong F, Ong R, **Rooney CM** , Tan J, Chen Q, Horak ID, Tan KW, Low L. Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models. Mol Ther. 2024 Jun 29. PMID: [38946142](//www.ncbi.nlm.nih.gov/pubmed/38946142).

Citations:  Fields:

Mol Molecular BiologyThe Therapeutics

  3. Lin FY, Stuckert A, Tat C, White M, Ruggieri L, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Major A, Thakkar S, Shum T, Parikh K, Wu MF, Lindsay HB, [Scherer L](https://profiles.viictr.org/profile/22016570), Shekar M, [Baxter P](https://profiles.viictr.org/profile/265524), Wang T, [Grilley B](https://profiles.viictr.org/profile/266987), [Moeller K](https://profiles.viictr.org/profile/51898388), Hicks J, [Roy A](https://profiles.viictr.org/profile/268647), [Anastas J](https://profiles.viictr.org/profile/33092477), Malbari F, Aldave G, [Chintagumpala M](https://profiles.viictr.org/profile/268049), [Blaney S](https://profiles.viictr.org/profile/268174), [Parsons DW](https://profiles.viictr.org/profile/265886), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Omer B](https://profiles.viictr.org/profile/3009902). Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 May 21; JCO2302019. PMID: [38771986](//www.ncbi.nlm.nih.gov/pubmed/38771986).

Citations:  Fields:

Neo Neoplasms

  4. [Quach DH](https://profiles.viictr.org/profile/3010661), Ganesh HR, Briones YD, Nouraee N, Ma A, Hadidi YF, Sharma S, **Rooney CM**. Rejection resistant CD30.CAR-modified Epstein-Barr virus-specific T?cells as an off-the-shelf platform for CD30+ lymphoma. Mol Ther Oncol. 2024 Jun 20; 32(2):200814. PMID: [38966037](//www.ncbi.nlm.nih.gov/pubmed/38966037); PMCID: [PMC11223124](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11223124).

Citations:

  5. Che-Hsing L, Sharma S, [Heczey AA](https://profiles.viictr.org/profile/268789), [Steffin DHM](https://profiles.viictr.org/profile/14348352), Louis CU, [Grilley BJ](https://profiles.viictr.org/profile/266987), Thakkar SG, Wu M, Wang T, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma. Res Sq. 2024 Apr 11. PMID: [38659815](//www.ncbi.nlm.nih.gov/pubmed/38659815); PMCID: [PMC11042400](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11042400).

Citations:

  6. [Shafer P](https://profiles.viictr.org/profile/24845191), Leung WK, Woods M, Choi JM, Rodriguez-Plata CM, [Maknojia A](https://profiles.viictr.org/profile/31189463), Mosquera A, [Somes LK](https://profiles.viictr.org/profile/28999354), Joubert J, Manliguez A, Ranjan R, [Burt B](https://profiles.viictr.org/profile/8354542), Lee HS, Zhang B, [Fuqua S](https://profiles.viictr.org/profile/269832), **Rooney C** , [Leen AM](https://profiles.viictr.org/profile/268626), [Hoyos V](https://profiles.viictr.org/profile/23479202). Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 2024 03; 26(3):266-275. PMID: [38231165](//www.ncbi.nlm.nih.gov/pubmed/38231165); PMCID: [PMC10922969](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10922969).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  7. Sharma S, Sauer T, [Omer BA](https://profiles.viictr.org/profile/3009902), Shum T, [Rollins LA](https://profiles.viictr.org/profile/28998998), **Rooney CM**. Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells. Int J Mol Sci. 2023 Oct 31; 24(21). PMID: [37958791](//www.ncbi.nlm.nih.gov/pubmed/37958791); PMCID: [PMC10649234](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10649234).

Citations:  Fields:

Bio BiochemistryChe ChemistryMol Molecular Biology

Translation:HumansAnimalsCells

  8. Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Izgutdina A, Escobar BP, Gorelik M, Ihling CH, Nix MA, Naik A, Xie WH, H?bner J, Rollins LA, Reid SM, Ramos E, Kasap C, Steri V, Serrano JAC, Salangsang F, Phojanakong P, McMillan M, Gavallos V, Leavitt AD, Logan AC, **Rooney CM** , Eyquem J, Sinz A, Huang BJ, Stieglitz E, Smith CC, Moritz RL, Sidhu SS, Huang L, Wiita AP. Structural surfaceomics reveals an AML-specific conformation of integrin ?2 as a CAR T cellular therapy target. Nat Cancer. 2023 Nov; 4(11):1592-1609. PMID: [37904046](//www.ncbi.nlm.nih.gov/pubmed/37904046); PMCID: [PMC10663162](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10663162).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37904046/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  9. [Vasileiou S](https://profiles.viictr.org/profile/22016531), Hill L, Kuvalekar M, Workineh AG, Watanabe A, Velazquez Y, [Lulla S](https://profiles.viictr.org/profile/34811365), Mooney K, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley BJ](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Eagar TN, [Carrum G](https://profiles.viictr.org/profile/269657), Grimes KA, [Leen AM](https://profiles.viictr.org/profile/268626), [Lulla P](https://profiles.viictr.org/profile/3010220). Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 2023 Jul 01; 108(7):1840-1850. PMID: [36373249](//www.ncbi.nlm.nih.gov/pubmed/36373249); PMCID: [PMC10316279](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10316279).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36373249/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  10. [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Velazquez Y, Watanabe A, [Narula M](https://profiles.viictr.org/profile/34768192), Workineh AG, French-Kim M, Chavez AT, Gilmore S, **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination. Haematologica. 2023 Jul 01; 108(7):1934-1939. PMID: [36373251](//www.ncbi.nlm.nih.gov/pubmed/36373251); PMCID: [PMC10316232](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10316232).

Citations:  Fields:

Hem Hematology

Translation:HumansCellsPHPublic Health

  11. Sharma S, [Woods M](https://profiles.viictr.org/profile/31330385), Mehta NU, Sauer T, Parikh KS, Schmuck-Henneresse M, Zhang H, Mehta B, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy. J Immunother Cancer. 2023 04; 11(4). PMID: [37072346](//www.ncbi.nlm.nih.gov/pubmed/37072346); PMCID: [PMC10124261](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10124261).

Citations:  Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  12. [Quach DH](https://profiles.viictr.org/profile/3010661), [Lulla P](https://profiles.viictr.org/profile/3010220), **Rooney CM**. Banking on virus-specific T cells to fulfill the need for?off-the-shelf cell therapies. Blood. 2023 02 23; 141(8):877-885. PMID: [36574622](//www.ncbi.nlm.nih.gov/pubmed/36574622); PMCID: [PMC10023738](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10023738).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  13. **Rooney CM** , Mitra S. A Practical Guide to 16S rRNA Microbiome Analysis in Musculoskeletal Disorders. Methods Mol Biol. 2023; 2649:85-105. PMID: [37258859](//www.ncbi.nlm.nih.gov/pubmed/37258859).

Citations:  Fields:

Mol Molecular Biology

Translation:HumansCells

  14. [Hoyos V](https://profiles.viictr.org/profile/23479202), [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, [Lulla S](https://profiles.viictr.org/profile/34811365), Robertson C, Foreman C, Wang T, Bulsara S, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley B](https://profiles.viictr.org/profile/266987), Ellis M, Osborne CK, Coscio A, [Nangia J](https://profiles.viictr.org/profile/266130), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Vera JF, [Lulla P](https://profiles.viictr.org/profile/3010220), [Rimawi M](https://profiles.viictr.org/profile/269416), [Leen AM](https://profiles.viictr.org/profile/268626). Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113. PMID: [35860837](//www.ncbi.nlm.nih.gov/pubmed/35860837); PMCID: [PMC9290161](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161).

Citations:

  15. [Steffin DHM](https://profiles.viictr.org/profile/14348352), Muhsen IN, Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Ahmed N](https://profiles.viictr.org/profile/268944), [Hegde M](https://profiles.viictr.org/profile/270076), Wang T, Wu M, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Whittle SB](https://profiles.viictr.org/profile/3009971), [Lulla PD](https://profiles.viictr.org/profile/3010220), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), [Heczey A](https://profiles.viictr.org/profile/268789), [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Grilley BJ](https://profiles.viictr.org/profile/266987), Robertson C, Torrano V, [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: [35325065](//www.ncbi.nlm.nih.gov/pubmed/35325065); PMCID: [PMC9346960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9346960).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  16. Naik S, [Vasileiou S](https://profiles.viictr.org/profile/22016531), Tzannou I, Kuvalekar M, Watanabe A, Robertson C, [Lapteva N](https://profiles.viictr.org/profile/269143), Tao W, Wu M, [Grilley B](https://profiles.viictr.org/profile/266987), [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), Hill L, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez C](https://profiles.viictr.org/profile/265827), Tewari P, [Omer B](https://profiles.viictr.org/profile/3009902), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, **Rooney CM** , Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626), [Lulla PD](https://profiles.viictr.org/profile/3010220). Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant?in patients with ALL. Blood. 2022 04 28; 139(17):2706-2711. PMID: [35134127](//www.ncbi.nlm.nih.gov/pubmed/35134127); PMCID: [PMC9053698](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9053698).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35134127/citedby/) Fields:

Hem Hematology

Translation:Humans

  17. [Omer B](https://profiles.viictr.org/profile/3009902), [Cardenas MG](https://profiles.viictr.org/profile/31194423), Pfeiffer T, Daum R, Huynh M, Sharma S, Nouraee N, Xie C, Tat C, Perconti S, [Van Pelt S](https://profiles.viictr.org/profile/28999342), [Scherer L](https://profiles.viictr.org/profile/22016570), DeRenzo C, Shum T, [Gottschalk S](https://profiles.viictr.org/profile/270181), Arber C, **Rooney CM**. A Costimulatory CAR Improves TCR-based Cancer Immunotherapy. Cancer Immunol Res. 2022 04 01; 10(4):512-524. PMID: [35176142](//www.ncbi.nlm.nih.gov/pubmed/35176142); PMCID: [PMC8978620](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8978620).

Citations:  Fields:

All Allergy and ImmunologyNeo Neoplasms

Translation:AnimalsCells

  18. Zhang X, Zhang R, Ren C, Xu Y, Wu S, Meng C, [Pataer A](https://profiles.viictr.org/profile/12582587), Song X, Zhang J, Yao Y, He H, Chen H, Ma W, Wang J, [Meric-Bernstam F](https://profiles.viictr.org/profile/12583329), [Champlin RE](https://profiles.viictr.org/profile/12582508), [Heymach JV](https://profiles.viictr.org/profile/12582703), **Rooney CM** , Swisher SG, [Vaporciyan AA](https://profiles.viictr.org/profile/12582580), [Roth JA](https://profiles.viictr.org/profile/12583652), You MJ, Wang M, Fang B. Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo. Blood Adv. 2022 02 08; 6(3):891-901. PMID: [34861697](//www.ncbi.nlm.nih.gov/pubmed/34861697); PMCID: [PMC8945299](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8945299).

Citations:  Fields:

Hem Hematology

Translation:HumansAnimalsCells

  19. Sauer T, Parikh K, Sharma S, [Omer B](https://profiles.viictr.org/profile/3009902), Sedloev D, Chen Q, Angenendt L, Schliemann C, Schmitt M, [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM** , M?ller-Tidow C. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 2021 07 29; 138(4):318-330. PMID: [34323938](//www.ncbi.nlm.nih.gov/pubmed/34323938); PMCID: [PMC8323977](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8323977).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34323938/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  20. Kim WS, [Oki Y](https://profiles.viictr.org/profile/12583414), Kim SJ, Yoon SE, Ardeshna KM, Lin Y, Ruan J, Porcu P, Brammer JE, Jacobsen ED, Yoon DH, Suh C, Radford J, Budde LE, Kim JS, Bachy E, Lee HJ, Bollard CM, Jaccard A, Kang HJ, Inman S, Murray M, Combs KE, Lee DY, Advani R, Gunter KC, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Suarez F. Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study. Ann Hematol. 2021 Oct; 100(10):2529-2539. PMID: [34304287](//www.ncbi.nlm.nih.gov/pubmed/34304287).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34304287/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  21. El Fiky A, Ibenana L, Anderson R, Hare JM, Khan A, [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney C** , McKenna DH, Gold J, Kelley L, Lundberg MS, Welniak LA, Lindblad R. The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy. Clin Transl Sci. 2021 11; 14(6):2099-2110. PMID: [34286927](//www.ncbi.nlm.nih.gov/pubmed/34286927); PMCID: [PMC8604220](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8604220).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34286927/citedby/) Fields:

Med Medicine (General)

  22. **Rooney CM** , McIntyre J, Ritchie L, Wilcox MH. Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2. Infect Prev Pract. 2021 Jun; 3(2):100144. PMID: [34316581](//www.ncbi.nlm.nih.gov/pubmed/34316581); PMCID: [PMC8081747](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8081747).

Citations:

  23. [Vasileiou S](https://profiles.viictr.org/profile/22016531), [Lulla PD](https://profiles.viictr.org/profile/3010220), Tzannou I, Watanabe A, Kuvalekar M, Callejas WL, Bilgi M, Wang T, Wu MJ, [Kamble R](https://profiles.viictr.org/profile/265557), [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce RH](https://profiles.viictr.org/profile/3010108), Zeng Z, [Gee AP](https://profiles.viictr.org/profile/268378), [Grilley BJ](https://profiles.viictr.org/profile/266987), Vera JF, Bollard CM, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626), [Carrum G](https://profiles.viictr.org/profile/269657). T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425. PMID: [33507803](//www.ncbi.nlm.nih.gov/pubmed/33507803); PMCID: [PMC8274795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8274795).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33507803/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  24. [Heslop HE](https://profiles.viictr.org/profile/269811), Sharma S, **Rooney CM**. Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas. J Clin Oncol. 2021 02 10; 39(5):514-524. PMID: [33434061](//www.ncbi.nlm.nih.gov/pubmed/33434061); PMCID: [PMC8462582](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8462582).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33434061/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  25. [Ramos CA](https://profiles.viictr.org/profile/267038), Grover NS, Beaven AW, [Lulla PD](https://profiles.viictr.org/profile/3010220), Wu MF, Ivanova A, Wang T, Shea TC, **Rooney CM** , Dittus C, Park SI, [Gee AP](https://profiles.viictr.org/profile/268378), Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, [Grilley BJ](https://profiles.viictr.org/profile/266987), Morrison K, [Brenner MK](https://profiles.viictr.org/profile/268200), Serody JS, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), Savoldo B. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol. 2020 11 10; 38(32):3794-3804. PMID: [32701411](//www.ncbi.nlm.nih.gov/pubmed/32701411); PMCID: [PMC7655020](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7655020).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32701411/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  26. Ando J, Ngo MC, Ando M, [Leen A](https://profiles.viictr.org/profile/268626), **Rooney CM**. Identification of protective T-cell antigens for smallpox vaccines. Cytotherapy. 2020 11; 22(11):642-652. PMID: [32747299](//www.ncbi.nlm.nih.gov/pubmed/32747299); PMCID: [PMC7205715](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7205715).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32747299/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansAnimalsCellsPHPublic Health

  27. Packiriswamy N, Upreti D, Zhou Y, Khan R, Miller A, Diaz RM, **Rooney CM** , Dispenzieri A, Peng KW, Russell SJ. Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma. Leukemia. 2020 12; 34(12):3310-3322. PMID: [32327728](//www.ncbi.nlm.nih.gov/pubmed/32327728); PMCID: [PMC7581629](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7581629).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32327728/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCellsCTClinical Trials

  28. [Lapteva N](https://profiles.viictr.org/profile/269143), Gilbert M, Diaconu I, [Rollins LA](https://profiles.viictr.org/profile/28998998), Al-Sabbagh M, Naik S, [Krance RA](https://profiles.viictr.org/profile/268199), Tripic T, Hiregange M, Raghavan D, Dakhova O, [Rouce RH](https://profiles.viictr.org/profile/3010108), Liu H, [Omer B](https://profiles.viictr.org/profile/3009902), Savoldo B, Dotti G, Cruz CR, Sharpe K, Gates M, Orozco A, Durett A, Pacheco E, [Gee AP](https://profiles.viictr.org/profile/268378), [Ramos CA](https://profiles.viictr.org/profile/267038), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells. Clin Cancer Res. 2019 12 15; 25(24):7340-7350. PMID: [31558475](//www.ncbi.nlm.nih.gov/pubmed/31558475); PMCID: [PMC7062259](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7062259).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31558475/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  29. [Quach DH](https://profiles.viictr.org/profile/3010661), Becerra-Dominguez L, [Rouce RH](https://profiles.viictr.org/profile/3010108), **Rooney CM**. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240. PMID: [31340822](//www.ncbi.nlm.nih.gov/pubmed/31340822); PMCID: [PMC6657103](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6657103).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31340822/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  30. Keller MD, Darko S, Lang H, Ransier A, Lazarski CA, Wang Y, Hanley PJ, Davila BJ, Heimall JR, Ambinder RF, Barrett AJ, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Douek DC, Bollard CM. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy. Br J Haematol. 2019 10; 187(2):206-218. PMID: [31219185](//www.ncbi.nlm.nih.gov/pubmed/31219185); PMCID: [PMC6786907](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6786907).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31219185/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  31. Sauer T, **Rooney CM**. Current challenges for CAR T-cell therapy of acute myeloid leukemia. Transfusion. 2019 04; 59(4):1171-1173. PMID: [30762880](//www.ncbi.nlm.nih.gov/pubmed/30762880).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30762880/citedby/) Fields:

Hem Hematology

Translation:HumansAnimals

  32. [Parihar R](https://profiles.viictr.org/profile/3009684), [Rivas C](https://profiles.viictr.org/profile/31189484), Huynh M, [Omer B](https://profiles.viictr.org/profile/3009902), [Lapteva N](https://profiles.viictr.org/profile/269143), [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Gottschalk SM](https://profiles.viictr.org/profile/270181), **Rooney CM**. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunol Res. 2019 03; 7(3):363-375. PMID: [30651290](//www.ncbi.nlm.nih.gov/pubmed/30651290); PMCID: [PMC7906796](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7906796).

Citations:
[83](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30651290/citedby/) Fields:

All Allergy and ImmunologyNeo Neoplasms

Translation:HumansAnimalsCells

  33. [Omer B](https://profiles.viictr.org/profile/3009902), Castillo PA, Tashiro H, Shum T, Huynh MTA, [Cardenas M](https://profiles.viictr.org/profile/31194423), Tanaka M, Lewis A, Sauer T, [Parihar R](https://profiles.viictr.org/profile/3009684), [Lapteva N](https://profiles.viictr.org/profile/269143), Schmueck-Henneresse M, Mukherjee M, [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM**. Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells. Front Med (Lausanne). 2018; 5:343. PMID: [30619856](//www.ncbi.nlm.nih.gov/pubmed/30619856); PMCID: [PMC6297364](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6297364).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30619856/citedby/)

  34. Kalra M, Gerdemann U, Luu JD, Ngo MC, [Leen AM](https://profiles.viictr.org/profile/268626), Louis CU, **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181). Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy. Cytotherapy. 2019 02; 21(2):212-223. PMID: [30396848](//www.ncbi.nlm.nih.gov/pubmed/30396848); PMCID: [PMC6435433](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6435433).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30396848/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  35. McLaughlin LP, [Rouce R](https://profiles.viictr.org/profile/3010108), [Gottschalk S](https://profiles.viictr.org/profile/270181), Torrano V, [Carrum G](https://profiles.viictr.org/profile/269657), Wu MF, Hoq F, [Grilley B](https://profiles.viictr.org/profile/266987), Marcogliese AM, Hanley PJ, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 2018 11 29; 132(22):2351-2361. PMID: [30262660](//www.ncbi.nlm.nih.gov/pubmed/30262660); PMCID: [PMC6265652](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6265652).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30262660/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  36. Sung JA, Patel S, Clohosey ML, Roesch L, Tripic T, Kuruc JD, Archin N, Hanley PJ, Cruz CR, Goonetilleke N, Eron JJ, **Rooney CM** , Gay CL, Bollard CM, Margolis DM. HIV-Specific, Ex?Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals. Mol Ther. 2018 10 03; 26(10):2496-2506. PMID: [30249388](//www.ncbi.nlm.nih.gov/pubmed/30249388); PMCID: [PMC6171327](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6171327).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30249388/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCellsCTClinical Trials

  37. [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce R](https://profiles.viictr.org/profile/3010108), Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Wu MF, Liu H, [Grilley B](https://profiles.viictr.org/profile/266987), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Savoldo B, Dotti G. In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas. Mol Ther. 2018 12 05; 26(12):2727-2737. PMID: [30309819](//www.ncbi.nlm.nih.gov/pubmed/30309819); PMCID: [PMC6277484](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6277484).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30309819/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  38. **Rooney C** , Sauer T. Modeling cytokine release syndrome. Nat Med. 2018 06; 24(6):705-706. PMID: [29808004](//www.ncbi.nlm.nih.gov/pubmed/29808004).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29808004/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCells

  39. Shum T, Kruse RL, **Rooney CM**. Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Expert Opin Biol Ther. 2018 06; 18(6):653-664. PMID: [29727246](//www.ncbi.nlm.nih.gov/pubmed/29727246); PMCID: [PMC6084433](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6084433).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29727246/citedby/) Fields:

Bio BiologyThe Therapeutics

Translation:HumansAnimalsCells

  40. O'Neil RT, Saha S, Veach RA, Welch RC, Woodard LE, **Rooney CM** , Wilson MH. Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo. Nat Commun. 2018 04 10; 9(1):1325. PMID: [29636469](//www.ncbi.nlm.nih.gov/pubmed/29636469); PMCID: [PMC5893599](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5893599).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29636469/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCellsPHPublic Health

  41. Castillo P, Wright KE, [Kontoyiannis DP](https://profiles.viictr.org/profile/12582577), Walsh T, Patel S, Chorvinsky E, Bose S, Hazrat Y, [Omer B](https://profiles.viictr.org/profile/3009902), Albert N, [Leen AM](https://profiles.viictr.org/profile/268626), **Rooney CM** , Bollard CM, Cruz CRY. A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae. Mol Ther Methods Clin Dev. 2018 Jun 15; 9:305-312. PMID: [30038934](//www.ncbi.nlm.nih.gov/pubmed/30038934); PMCID: [PMC6054701](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6054701).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30038934/citedby/)

  42. Bollard CM, Tripic T, Cruz CR, Dotti G, [Gottschalk S](https://profiles.viictr.org/profile/270181), Torrano V, Dakhova O, [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), Liu H, Wu MF, [Marcogliese AN](https://profiles.viictr.org/profile/266792), Barese C, Zu Y, Lee DY, O'Connor O, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma. J Clin Oncol. 2018 04 10; 36(11):1128-1139. PMID: [29315015](//www.ncbi.nlm.nih.gov/pubmed/29315015); PMCID: [PMC5891126](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5891126).

Citations:
[75](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29315015/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  43. Morita D, Nishio N, Saito S, Tanaka M, Kawashima N, Okuno Y, Suzuki S, Matsuda K, Maeda Y, Wilson MH, Dotti G, **Rooney CM** , Takahashi Y, Nakazawa Y. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells. Mol Ther Methods Clin Dev. 2018 Mar 16; 8:131-140. PMID: [29687032](//www.ncbi.nlm.nih.gov/pubmed/29687032); PMCID: [PMC5907825](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5907825).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29687032/citedby/)

  44. Mukherjee M, Srinivasan M, Krenciute G, Dakhova O, Zheng Y, **Rooney CM** , Orange JS, [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306), Gomes-Silva D, Cabral JMS. Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent. Cell Rep. 2017 Oct 03; 21(1):17-26. PMID: [28978471](//www.ncbi.nlm.nih.gov/pubmed/28978471); PMCID: [PMC5645034](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5645034).

Citations:
[92](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28978471/citedby/) Fields:

Cel Cell BiologyMol Molecular Biology

Translation:HumansAnimalsCells

  45. Boyiadzis M, Agha M, Redner RL, Sehgal A, Im A, Hou JZ, Farah R, Dorritie KA, Raptis A, Lim SH, Wang H, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Butterfield LH, **Rooney CM** , Whiteside TL. Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. Cytotherapy. 2017 10; 19(10):1225-1232. PMID: [28864289](//www.ncbi.nlm.nih.gov/pubmed/28864289).

Citations:
[66](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28864289/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCellsCTClinical Trials

  46. Shum T, [Omer B](https://profiles.viictr.org/profile/3009902), Tashiro H, Kruse RL, [Wagner DL](https://profiles.viictr.org/profile/45193203), Parikh K, Yi Z, Sauer T, Liu D, [Parihar R](https://profiles.viictr.org/profile/3009684), Castillo P, Liu H, [Brenner MK](https://profiles.viictr.org/profile/268200), [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM**. Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discov. 2017 11; 7(11):1238-1247. PMID: [28830878](//www.ncbi.nlm.nih.gov/pubmed/28830878); PMCID: [PMC5669830](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5669830).

Citations:
[93](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28830878/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  47. [Ramos CA](https://profiles.viictr.org/profile/267038), Ballard B, Zhang H, Dakhova O, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Bilgi M, Wu MF, Liu H, [Grilley B](https://profiles.viictr.org/profile/266987), Bollard CM, Chang BH, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, Savoldo B. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes. J Clin Invest. 2017 Sep 01; 127(9):3462-3471. PMID: [28805662](//www.ncbi.nlm.nih.gov/pubmed/28805662); PMCID: [PMC5669573](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5669573).

Citations:
[140](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28805662/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  48. Tzannou I, Papadopoulou A, Naik S, Leung K, [Martinez CA](https://profiles.viictr.org/profile/265827), [Ramos CA](https://profiles.viictr.org/profile/267038), [Carrum G](https://profiles.viictr.org/profile/269657), Sasa G, [Lulla P](https://profiles.viictr.org/profile/3010220), Watanabe A, Kuvalekar M, [Gee AP](https://profiles.viictr.org/profile/268378), Wu MF, Liu H, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Krance RA](https://profiles.viictr.org/profile/268199), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), [Omer B](https://profiles.viictr.org/profile/3009902). Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 01; 35(31):3547-3557. PMID: [28783452](//www.ncbi.nlm.nih.gov/pubmed/28783452); PMCID: [PMC5662844](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5662844).

Citations:
[135](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28783452/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  49. [Ahmed N](https://profiles.viictr.org/profile/268944), Brawley V, [Hegde M](https://profiles.viictr.org/profile/270076), Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, **Rooney C** , Dotti G, [Gee A](https://profiles.viictr.org/profile/268378), [Su J](https://profiles.viictr.org/profile/268196), Kew Y, Baskin D, Zhang YJ, New P, [Grilley B](https://profiles.viictr.org/profile/266987), Stojakovic M, Hicks J, [Powell SZ](https://profiles.viictr.org/profile/269823), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Grossman R, Wels WS, [Gottschalk S](https://profiles.viictr.org/profile/270181). HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol. 2017 Aug 01; 3(8):1094-1101. PMID: [28426845](//www.ncbi.nlm.nih.gov/pubmed/28426845); PMCID: [PMC5747970](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5747970).

Citations:
[269](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28426845/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  50. Tashiro H, Sauer T, Shum T, Parikh K, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), [Lulla P](https://profiles.viictr.org/profile/3010220), **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200). Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213. PMID: [28676343](//www.ncbi.nlm.nih.gov/pubmed/28676343); PMCID: [PMC5589064](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589064).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28676343/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  51. [Heczey A](https://profiles.viictr.org/profile/268789), Louis CU, Savoldo B, Dakhova O, Durett A, [Grilley B](https://profiles.viictr.org/profile/266987), Liu H, Wu MF, [Mei Z](https://profiles.viictr.org/profile/267093), [Gee A](https://profiles.viictr.org/profile/268378), Mehta B, Zhang H, [Mahmood N](https://profiles.viictr.org/profile/269285), Tashiro H, [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200). CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017 09 06; 25(9):2214-2224. PMID: [28602436](//www.ncbi.nlm.nih.gov/pubmed/28602436); PMCID: [PMC5589058](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589058).

Citations:
[168](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28602436/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  52. [Omer B](https://profiles.viictr.org/profile/3009902), Shum T, Tashiro H, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Lapteva N](https://profiles.viictr.org/profile/269143), Sharma S, [Rollins L](https://profiles.viictr.org/profile/28998998), Dotti G, **Rooney CM** , Schmueck-Henneresse M, Reinke P, Volk HD. Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells. J Immunol. 2017 07 01; 199(1):348-362. PMID: [28550199](//www.ncbi.nlm.nih.gov/pubmed/28550199); PMCID: [PMC5536854](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5536854).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28550199/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  53. Tanaka M, Tashiro H, [Omer B](https://profiles.viictr.org/profile/3009902), Lapteva N, Ando J, Ngo M, Mehta B, Dotti G, Kinchington PR, [Leen AM](https://profiles.viictr.org/profile/268626), Rossig C, **Rooney CM**. Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clin Cancer Res. 2017 Jul 15; 23(14):3499-3509. PMID: [28183713](//www.ncbi.nlm.nih.gov/pubmed/28183713); PMCID: [PMC5511585](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5511585).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28183713/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials

  54. Mohammed S, Sukumaran S, Bajgain P, [Watanabe N](https://profiles.viictr.org/profile/3009961), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Fisher WE](https://profiles.viictr.org/profile/267699), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Mol Ther. 2017 01 04; 25(1):249-258. PMID: [28129119](//www.ncbi.nlm.nih.gov/pubmed/28129119); PMCID: [PMC5363304](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5363304).

Citations:
[112](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28129119/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  55. McLaughlin LP, [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM** , Bollard CM. EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas. Methods Mol Biol. 2017; 1532:255-265. PMID: [27873282](//www.ncbi.nlm.nih.gov/pubmed/27873282).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27873282/citedby/) Fields:

Mol Molecular Biology

Translation:HumansCells

  56. [Watanabe N](https://profiles.viictr.org/profile/3009961), Bajgain P, Sukumaran S, Ansari S, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016; 5(12):e1253656. PMID: [28180032](//www.ncbi.nlm.nih.gov/pubmed/28180032); PMCID: [PMC5214260](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5214260).

Citations:
[78](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28180032/citedby/) Fields:

All Allergy and ImmunologyNeo Neoplasms

  57. Gundry MC, Brunetti L, Lin A, Mayle AE, Kitano A, Hsu JI, Hoegenauer KA, **Rooney CM** , [Goodell MA](https://profiles.viictr.org/profile/269806), [Nakada D](https://profiles.viictr.org/profile/268530), [Wagner D](https://profiles.viictr.org/profile/45193203). Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. Cell Rep. 2016 10 25; 17(5):1453-1461. PMID: [27783956](//www.ncbi.nlm.nih.gov/pubmed/27783956); PMCID: [PMC5087995](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5087995).

Citations:
[114](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27783956/citedby/)
Fields:

Cel Cell BiologyMol Molecular Biology

Translation:HumansAnimalsCells

  58. [Ramos CA](https://profiles.viictr.org/profile/267038), Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Wu MF, Liu H, [Grilley B](https://profiles.viictr.org/profile/266987), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016 07 01; 126(7):2588-96. PMID: [27270177](//www.ncbi.nlm.nih.gov/pubmed/27270177); PMCID: [PMC4922690](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4922690).

Citations:
[131](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27270177/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  59. Naik S, [Nicholas SK](https://profiles.viictr.org/profile/270011), [Martinez CA](https://profiles.viictr.org/profile/265827), [Leen AM](https://profiles.viictr.org/profile/268626), Hanley PJ, Gottschalk SM, **Rooney CM** , Hanson IC, [Krance RA](https://profiles.viictr.org/profile/268199), [Shpall EJ](https://profiles.viictr.org/profile/12582631), Cruz CR, Amrolia P, Lucchini G, Bunin N, Heimall J, Klein OR, Gennery AR, Slatter MA, Vickers MA, Orange JS, [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM, Keller MD. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016 05; 137(5):1498-1505.e1. PMID: [26920464](//www.ncbi.nlm.nih.gov/pubmed/26920464); PMCID: [PMC4860050](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4860050).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26920464/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  60. [Lapteva N](https://profiles.viictr.org/profile/269143), [Parihar R](https://profiles.viictr.org/profile/3009684), [Rollins LA](https://profiles.viictr.org/profile/28998998), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM**. Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy. Methods Mol Biol. 2016; 1441:195-202. PMID: [27177667](//www.ncbi.nlm.nih.gov/pubmed/27177667).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27177667/citedby/) Fields:

Mol Molecular Biology

Translation:HumansCells

  61. Galvan DL, O'Neil RT, Foster AE, Huye L, Bear A, **Rooney CM** , Wilson MH. Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model. PLoS One. 2015; 10(10):e0140744. PMID: [26473608](//www.ncbi.nlm.nih.gov/pubmed/26473608); PMCID: [PMC4608718](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4608718).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26473608/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:HumansAnimalsCells

  62. Manzo T, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Antigen-specific T cell therapies for cancer. Hum Mol Genet. 2015 Oct 15; 24(R1):R67-73. PMID: [26160910](//www.ncbi.nlm.nih.gov/pubmed/26160910); PMCID: [PMC4572005](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4572005).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26160910/citedby/) Fields:

Gen GeneticsMol Molecular Biology

Translation:HumansCells

  63. Zhou X, Dotti G, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez CA](https://profiles.viictr.org/profile/265827), Naik S, [Kamble RT](https://profiles.viictr.org/profile/265557), Durett AG, Dakhova O, Savoldo B, Di Stasi A, Spencer DM, Lin YF, [Liu H](https://profiles.viictr.org/profile/265543), [Grilley BJ](https://profiles.viictr.org/profile/266987), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200). Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015 Jun 25; 125(26):4103-13. PMID: [25977584](//www.ncbi.nlm.nih.gov/pubmed/25977584); PMCID: [PMC4481597](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4481597).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25977584/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  64. Ninomiya S, Narala N, Huye L, Yagyu S, Savoldo B, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Ramos CA](https://profiles.viictr.org/profile/267038). Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs. Blood. 2015 Jun 18; 125(25):3905-16. PMID: [25940712](//www.ncbi.nlm.nih.gov/pubmed/25940712); PMCID: [PMC4473118](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4473118).

Citations:
[125](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25940712/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  65. Hanley PJ, Melenhorst JJ, Nikiforow S, Scheinberg P, Blaney JW, Demmler-Harrison G, Cruz CR, Lam S, [Krance RA](https://profiles.viictr.org/profile/268199), Leung KS, [Martinez CA](https://profiles.viictr.org/profile/265827), Liu H, Douek DC, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Shpall EJ](https://profiles.viictr.org/profile/12582631), Barrett AJ, Rodgers JR, Bollard CM. CMV-specific T cells generated from na?ve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015 Apr 29; 7(285):285ra63. PMID: [25925682](//www.ncbi.nlm.nih.gov/pubmed/25925682); PMCID: [PMC4479400](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4479400).

Citations:
[43](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25925682/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:HumansCells

  66. **Rooney CM** , Schmueck-Henneresse M, Sharaf R, Vogt K, Weist BJ, Landwehr-Kenzel S, Fuehrer H, Jurisch A, Babel N, Reinke P, Volk HD. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015 Jun 01; 194(11):5559-67. PMID: [25917088](//www.ncbi.nlm.nih.gov/pubmed/25917088).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25917088/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  67. [Ahmed N](https://profiles.viictr.org/profile/268944), Brawley VS, [Hegde M](https://profiles.viictr.org/profile/270076), Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), Hicks J, [Rainusso N](https://profiles.viictr.org/profile/265526), Dotti G, [Mei Z](https://profiles.viictr.org/profile/267093), [Grilley B](https://profiles.viictr.org/profile/266987), [Gee A](https://profiles.viictr.org/profile/268378), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Wels WS, [Wang LL](https://profiles.viictr.org/profile/267005), Anderson P, [Gottschalk S](https://profiles.viictr.org/profile/270181). Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96. PMID: [25800760](//www.ncbi.nlm.nih.gov/pubmed/25800760); PMCID: [PMC4429176](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4429176).

Citations:
[373](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25800760/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  68. Sun J, Huye LE, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mamonkin M](https://profiles.viictr.org/profile/1826306), Hiregange M, Ballard B, Dakhova O, Raghavan D, Durett AG, Perna SK, [Omer B](https://profiles.viictr.org/profile/3009902), [Rollins LA](https://profiles.viictr.org/profile/28998998), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF, Dotti G, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), Myers DG, **Rooney CM**. Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application. J Immunother Cancer. 2015; 3:5. PMID: [25734008](//www.ncbi.nlm.nih.gov/pubmed/25734008); PMCID: [PMC4346112](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4346112).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25734008/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

  69. Saha S, Woodard LE, Charron EM, Welch RC, **Rooney CM** , Wilson MH. Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells. Nucleic Acids Res. 2015 Feb 18; 43(3):1770-82. PMID: [25605795](//www.ncbi.nlm.nih.gov/pubmed/25605795); PMCID: [PMC4330379](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4330379).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25605795/citedby/) Fields:

Bio Biochemistry

Translation:HumansCells

  70. Sung JA, Lam S, Garrido C, Archin N, **Rooney CM** , Bollard CM, Margolis DM. Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir. J Infect Dis. 2015 Jul 15; 212(2):258-63. PMID: [25589335](//www.ncbi.nlm.nih.gov/pubmed/25589335); PMCID: [PMC4490234](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4490234).

Citations:
[53](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25589335/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCells

  71. [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM**. Adoptive T-Cell Immunotherapy. Curr Top Microbiol Immunol. 2015; 391:427-54. PMID: [26428384](//www.ncbi.nlm.nih.gov/pubmed/26428384); PMCID: [PMC4655436](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4655436).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26428384/citedby/) Fields:

All Allergy and ImmunologyMic Microbiology

Translation:HumansAnimalsCells

  72. [Lapteva N](https://profiles.viictr.org/profile/269143), Garg T, Greenway A, Lingo J, Nair B, Stone K, Woods E, [Khan J](https://profiles.viictr.org/profile/51399074), Stivers J, Panozzo S, Campana D, Bellamy WT, Robbins M, Epstein J, Yaccoby S, Waheed S, [Gee A](https://profiles.viictr.org/profile/268378), Cottler-Fox M, **Rooney C** , Barlogie B, van Rhee F, Szmania S. Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients. J Immunother. 2015 Jan; 38(1):24-36. PMID: [25415285](//www.ncbi.nlm.nih.gov/pubmed/25415285); PMCID: [PMC4352951](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4352951).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25415285/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  73. Cripe TP, Ngo MC, Geller JI, Louis CU, Currier MA, Racadio JM, Towbin AJ, **Rooney CM** , Pelusio A, Moon A, Hwang TH, Burke JM, Bell JC, Kirn DH, Breitbach CJ. Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients. Mol Ther. 2015 Mar; 23(3):602-8. PMID: [25531693](//www.ncbi.nlm.nih.gov/pubmed/25531693); PMCID: [PMC4351466](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4351466).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25531693/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCellsPHPublic HealthCTClinical Trials

  74. Farzad L, Cerullo V, Yagyu S, Bertin T, Hemminki A, **Rooney C** , Lee B, [Suzuki M](https://profiles.viictr.org/profile/265870). Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy. Mol Ther Oncolytics. 2014; 1:14008. PMID: [27119096](//www.ncbi.nlm.nih.gov/pubmed/27119096); PMCID: [PMC4782941](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4782941).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27119096/citedby/)

  75. Lam S, Sung J, Cruz C, Castillo-Caro P, Ngo M, Garrido C, Kuruc J, Archin N, **Rooney C** , Margolis D, Bollard C. Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy. Mol Ther. 2015 Feb; 23(2):387-95. PMID: [25366030](//www.ncbi.nlm.nih.gov/pubmed/25366030); PMCID: [PMC4445615](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4445615).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25366030/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  76. Lindblad RW, Ibenana L, Wagner JE, McKenna DH, Hei DJ, Hematti P, Couture LA, Silberstein LE, Armant M, **Rooney CM** , [Gee AP](https://profiles.viictr.org/profile/268378), Welniak LA, Heath Mondoro T, Wood DA, Styers D. Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. Transfusion. 2015 Mar; 55(3):674-9. PMID: [25315143](//www.ncbi.nlm.nih.gov/pubmed/25315143); PMCID: [PMC4357544](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4357544).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25315143/citedby/) Fields:

Hem Hematology

Translation:Humans

  77. Vera JF, Gerken C, **Rooney CM** , Miller T, Pfent C, [Wang LL](https://profiles.viictr.org/profile/267005), Wilson-Robles HM, [Gottschalk S](https://profiles.viictr.org/profile/270181), Mata M. Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells. J Immunother. 2014 Oct; 37(8):407-15. PMID: [25198528](//www.ncbi.nlm.nih.gov/pubmed/25198528); PMCID: [PMC4163948](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4163948).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25198528/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  78. Melenhorst JJ, Castillo P, Hanley PJ, Keller MD, [Krance RA](https://profiles.viictr.org/profile/268199), [Margolin J](https://profiles.viictr.org/profile/268091), [Leen AM](https://profiles.viictr.org/profile/268626), [Heslop HE](https://profiles.viictr.org/profile/269811), Barrett AJ, **Rooney CM** , Bollard CM. Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells. Mol Ther. 2015 Jan; 23(1):179-83. PMID: [25266309](//www.ncbi.nlm.nih.gov/pubmed/25266309); PMCID: [PMC4426803](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4426803).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25266309/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  79. Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R, Maeda Y, Sato Y, Okabe S, Inukai T, Sugita K, Wilson MH, **Rooney CM** , Koike K. Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Cytotherapy. 2014 Sep; 16(9):1257-69. PMID: [25108652](//www.ncbi.nlm.nih.gov/pubmed/25108652); PMCID: [PMC4948190](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4948190).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25108652/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  80. Bollard CM, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Reply to S. Yuan et al. J Clin Oncol. 2014 Sep 01; 32(25):2820-1. PMID: [25049328](//www.ncbi.nlm.nih.gov/pubmed/25049328); PMCID: [PMC4145187](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4145187).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCells

  81. Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, [Liu H](https://profiles.viictr.org/profile/265543), [Martinez C](https://profiles.viictr.org/profile/265827), Leung K, [Carrum G](https://profiles.viictr.org/profile/269657), [Gee AP](https://profiles.viictr.org/profile/268378), Vera JF, [Krance RA](https://profiles.viictr.org/profile/268199), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626). Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014 Jun 25; 6(242):242ra83. PMID: [24964991](//www.ncbi.nlm.nih.gov/pubmed/24964991); PMCID: [PMC4181611](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4181611).

Citations:
[158](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24964991/citedby/)
Fields:

Med Medicine (General)Sci Science

Translation:HumansCellsCTClinical Trials

  82. **Rooney CM**. Can Treg elimination enhance NK cell therapy for AML? Blood. 2014 Jun 19; 123(25):3848-9. PMID: [24948620](//www.ncbi.nlm.nih.gov/pubmed/24948620).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24948620/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  83. Bajgain P, Mucharla R, Wilson J, Welch D, Anurathapan U, Liang B, Lu X, Ripple K, Centanni JM, Hall C, Hsu D, Couture LA, Gupta S, [Gee AP](https://profiles.viictr.org/profile/268378), [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), **Rooney CM** , Vera JF. Optimizing the production of suspension cells using the G-Rex "M" series. Mol Ther Methods Clin Dev. 2014; 1:14015. PMID: [26015959](//www.ncbi.nlm.nih.gov/pubmed/26015959); PMCID: [PMC4362380](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4362380).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26015959/citedby/)

  84. Miller JS, **Rooney CM** , Curtsinger J, McElmurry R, McCullar V, Verneris MR, [Lapteva N](https://profiles.viictr.org/profile/269143), McKenna D, Wagner JE, Blazar BR, Tolar J. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in?vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014 Aug; 20(8):1252-7. PMID: [24816582](//www.ncbi.nlm.nih.gov/pubmed/24816582); PMCID: [PMC4099265](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4099265).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24816582/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansAnimalsCells

  85. Ando J, [Leen AM](https://profiles.viictr.org/profile/268626), Ennamuri S, [Lapteva N](https://profiles.viictr.org/profile/269143), Vera JF, Min-Venditti A, Mims MP, [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM, [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM** , Ngo MC. Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203. PMID: [24714353](//www.ncbi.nlm.nih.gov/pubmed/24714353); PMCID: [PMC4133102](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4133102).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24714353/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  86. Xu Y, Zhang M, [Ramos CA](https://profiles.viictr.org/profile/267038), Durett A, Liu E, Dakhova O, [Liu H](https://profiles.viictr.org/profile/265543), [Creighton CJ](https://profiles.viictr.org/profile/265729), [Gee AP](https://profiles.viictr.org/profile/268378), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Savoldo B, Dotti G. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014 Jun 12; 123(24):3750-9. PMID: [24782509](//www.ncbi.nlm.nih.gov/pubmed/24782509); PMCID: [PMC4055922](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4055922).

Citations:
[263](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24782509/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCellsCTClinical Trials

  87. Zhou X, Di Stasi A, Tey SK, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez C](https://profiles.viictr.org/profile/265827), Leung KS, Durett AG, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), [Leen AM](https://profiles.viictr.org/profile/268626), Savoldo B, Lin YF, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Gee AP](https://profiles.viictr.org/profile/268378), Spencer DM, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 2014 Jun 19; 123(25):3895-905. PMID: [24753538](//www.ncbi.nlm.nih.gov/pubmed/24753538); PMCID: [PMC4064331](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4064331).

Citations:
[86](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24753538/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCellsCTClinical Trials

  88. Papadopoulou A, [Krance RA](https://profiles.viictr.org/profile/268199), [Allen CE](https://profiles.viictr.org/profile/270283), Lee D, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), [Heslop HE](https://profiles.viictr.org/profile/269811). Systemic inflammatory response syndrome after administration of unmodified T lymphocytes. Mol Ther. 2014 Jun; 22(6):1134-1138. PMID: [24651135](//www.ncbi.nlm.nih.gov/pubmed/24651135); PMCID: [PMC4048900](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4048900).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24651135/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  89. Wood D, Wesselschmidt R, Hematti P, [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney C** , Silberstein L, Armant M, Couture L, Wagner JE, McKenna DH, Hei D, Mondoro TH, Welniak L, Lindblad R. An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy. Clin Transl Sci. 2014 Apr; 7(2):93-9. PMID: [24655892](//www.ncbi.nlm.nih.gov/pubmed/24655892); PMCID: [PMC4006308](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4006308).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24655892/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  90. [Leen AM](https://profiles.viictr.org/profile/268626), Sukumaran S, [Watanabe N](https://profiles.viictr.org/profile/3009961), Mohammed S, Keirnan J, Yanagisawa R, Anurathapan U, Rendon D, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Vera JF. Reversal of tumor immune inhibition using a chimeric cytokine receptor. Mol Ther. 2014 Jun; 22(6):1211-1220. PMID: [24732709](//www.ncbi.nlm.nih.gov/pubmed/24732709); PMCID: [PMC4048899](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4048899).

Citations:
[82](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24732709/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  91. [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM**. Harnessing the immune system to potentiate oncolytics. Mol Ther. 2014 Feb; 22(2):239-240. PMID: [24487560](//www.ncbi.nlm.nih.gov/pubmed/24487560); PMCID: [PMC3916053](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3916053).

Citations:  Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  92. [Lapteva N](https://profiles.viictr.org/profile/269143), Szmania SM, van Rhee F, **Rooney CM**. Clinical grade purification and expansion of natural killer cells. Crit Rev Oncog. 2014; 19(1-2):121-32. PMID: [24941378](//www.ncbi.nlm.nih.gov/pubmed/24941378); PMCID: [PMC4095851](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4095851).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24941378/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  93. **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF, [Heslop HE](https://profiles.viictr.org/profile/269811). T lymphocytes targeting native receptors. Immunol Rev. 2014 Jan; 257(1):39-55. PMID: [24329788](//www.ncbi.nlm.nih.gov/pubmed/24329788); PMCID: [PMC3869095](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3869095).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24329788/citedby/) Fields:

All Allergy and ImmunologyTra Transplantation

Translation:HumansAnimalsCells

  94. Bollard CM, [Gottschalk S](https://profiles.viictr.org/profile/270181), Torrano V, Diouf O, Ku S, Hazrat Y, [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos C](https://profiles.viictr.org/profile/267038), [Fayad L](https://profiles.viictr.org/profile/12582534), [Shpall EJ](https://profiles.viictr.org/profile/12582631), Pro B, [Liu H](https://profiles.viictr.org/profile/265543), Wu MF, Lee D, Sheehan AM, Zu Y, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol. 2014 Mar 10; 32(8):798-808. PMID: [24344220](//www.ncbi.nlm.nih.gov/pubmed/24344220); PMCID: [PMC3940538](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3940538).

Citations:
[208](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24344220/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  95. Anurathapan U, Chan RC, Hindi HF, Mucharla R, Bajgain P, Hayes BC, [Fisher WE](https://profiles.viictr.org/profile/267699), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Kinetics of tumor destruction by chimeric antigen receptor-modified T cells. Mol Ther. 2014 Mar; 22(3):623-633. PMID: [24213558](//www.ncbi.nlm.nih.gov/pubmed/24213558); PMCID: [PMC3945803](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3945803).

Citations:
[60](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24213558/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  96. Cruz CR, Lam S, Hanley PJ, Bear AS, Langston C, Cohen AJ, [Liu H](https://profiles.viictr.org/profile/265543), [Martinez CA](https://profiles.viictr.org/profile/265827), [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Hanson IC, Bollard CM. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clin Exp Immunol. 2013 Oct; 174(1):89-96. PMID: [23763437](//www.ncbi.nlm.nih.gov/pubmed/23763437); PMCID: [PMC3784216](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3784216).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23763437/citedby/) Fields:

All Allergy and Immunology

Translation:HumansAnimalsCells

  97. Cruz CR, Micklethwaite KP, Savoldo B, [Ramos CA](https://profiles.viictr.org/profile/267038), Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, [Shpall EJ](https://profiles.viictr.org/profile/12582631), [Krance RA](https://profiles.viictr.org/profile/268199), [Kamble RT](https://profiles.viictr.org/profile/265557), [Carrum G](https://profiles.viictr.org/profile/269657), [Hosing CM](https://profiles.viictr.org/profile/12583741), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), [Grilley BJ](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Bollard CM, Dotti G. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013 Oct 24; 122(17):2965-73. PMID: [24030379](//www.ncbi.nlm.nih.gov/pubmed/24030379); PMCID: [PMC3811171](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3811171).

Citations:
[231](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24030379/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  98. Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, [Craddock JA](https://profiles.viictr.org/profile/27841637), [Liu H](https://profiles.viictr.org/profile/265543), [Martinez CA](https://profiles.viictr.org/profile/265827), Kennedy-Nasser A, Leung KS, [Gottschalk SM](https://profiles.viictr.org/profile/270181), [Krance RA](https://profiles.viictr.org/profile/268199), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626). Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther. 2013 Nov; 21(11):2113-21. PMID: [23783429](//www.ncbi.nlm.nih.gov/pubmed/23783429); PMCID: [PMC3831033](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3831033).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23783429/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCellsCTClinical Trials

  99. [Leen AM](https://profiles.viictr.org/profile/268626), Bollard CM, Mendizabal AM, [Shpall EJ](https://profiles.viictr.org/profile/12582631), Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, [Kebriaei P](https://profiles.viictr.org/profile/12582909), Dey BR, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013 Jun 27; 121(26):5113-23. PMID: [23610374](//www.ncbi.nlm.nih.gov/pubmed/23610374); PMCID: [PMC3695359](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3695359).

Citations:
[209](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23610374/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  100. Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M, Cho M, Lim HY, Chung HC, Kim CW, Burke J, Lencioni R, Hickman T, Moon A, Lee YS, Kim MK, Daneshmand M, Dubois K, Longpre L, Ngo M, **Rooney C** , Bell JC, Rhee BG, Patt R, Hwang TH, Kirn DH. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med. 2013 Mar; 19(3):329-36. PMID: [23396206](//www.ncbi.nlm.nih.gov/pubmed/23396206); PMCID: [PMC4268543](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4268543).

Citations:
[349](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23396206/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCellsCTClinical Trials

  101. Sanchez C, Chan R, Bajgain P, Rambally S, Palapattu G, Mims M, **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626), Brenner MK, Vera JF. Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):123-31, S1. PMID: [23295316](//www.ncbi.nlm.nih.gov/pubmed/23295316); PMCID: [PMC3883310](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3883310).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23295316/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCells

  102. Nakazawa Y, Saha S, Galvan DL, Huye L, [Rollins L](https://profiles.viictr.org/profile/28998998), **Rooney CM** , Wilson MH. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. J Immunother. 2013 Jan; 36(1):3-10. PMID: [23211626](//www.ncbi.nlm.nih.gov/pubmed/23211626); PMCID: [PMC3521868](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3521868).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23211626/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  103. [Ramos CA](https://profiles.viictr.org/profile/267038), Narala N, Vyas GM, [Leen AM](https://profiles.viictr.org/profile/268626), Gerdemann U, [Sturgis EM](https://profiles.viictr.org/profile/12582951), Anderson ML, Savoldo B, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies. J Immunother. 2013 Jan; 36(1):66-76. PMID: [23211628](//www.ncbi.nlm.nih.gov/pubmed/23211628); PMCID: [PMC3521877](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3521877).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23211628/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  104. Chakraborty R, Mahendravada A, Perna SK, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Vera JF, Savoldo B, Dotti G. Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease. Haematologica. 2013 Apr; 98(4):533-7. PMID: [23242592](//www.ncbi.nlm.nih.gov/pubmed/23242592); PMCID: [PMC3659983](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3659983).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23242592/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  105. [Suzuki M](https://profiles.viictr.org/profile/265870), **Rooney CM**. Adenovirus immunity: X marks the spot. Mol Ther. 2012 Dec; 20(12):2197-8. PMID: [23201614](//www.ncbi.nlm.nih.gov/pubmed/23201614); PMCID: [PMC3519998](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3519998).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23201614/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  106. Gerdemann U, Keukens L, Keirnan JM, Katari UL, Nguyen CT, de Pagter AP, [Ramos CA](https://profiles.viictr.org/profile/267038), Kennedy-Nasser A, [Gottschalk SM](https://profiles.viictr.org/profile/270181), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood. 2013 Jan 03; 121(1):207-18. PMID: [23152545](//www.ncbi.nlm.nih.gov/pubmed/23152545); PMCID: [PMC3709638](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709638).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23152545/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  107. Perna SK, De Angelis B, Pagliara D, Hasan ST, Zhang L, Mahendravada A, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , Dotti G, Savoldo B. Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma. Clin Cancer Res. 2013 Jan 01; 19(1):106-17. PMID: [23149818](//www.ncbi.nlm.nih.gov/pubmed/23149818); PMCID: [PMC3693218](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3693218).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23149818/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  108. **Rooney C** , [Leen A](https://profiles.viictr.org/profile/268626). Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials. Mol Ther Nucleic Acids. 2012 Nov 13; 1:e55. PMID: [23629030](//www.ncbi.nlm.nih.gov/pubmed/23629030); PMCID: [PMC3511676](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3511676).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23629030/citedby/)

  109. Saha S, Nakazawa Y, Huye LE, Doherty JE, Galvan DL, **Rooney CM** , Wilson MH. piggyBac transposon system modification of primary human T cells. J Vis Exp. 2012 Nov 05; (69):e4235. PMID: [23149543](//www.ncbi.nlm.nih.gov/pubmed/23149543); PMCID: [PMC3514050](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3514050).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23149543/citedby/) Fields:

Bio BiologyMed Medicine (General)

Translation:HumansCells

  110. [Lapteva N](https://profiles.viictr.org/profile/269143), Durett AG, Sun J, [Rollins LA](https://profiles.viictr.org/profile/28998998), Huye LL, Fang J, Dandekar V, [Mei Z](https://profiles.viictr.org/profile/267093), Jackson K, Vera J, Ando J, Ngo MC, Coustan-Smith E, Campana D, Szmania S, Garg T, Moreno-Bost A, Vanrhee F, [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM**. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 2012 Oct; 14(9):1131-43. PMID: [22900959](//www.ncbi.nlm.nih.gov/pubmed/22900959); PMCID: [PMC4787300](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4787300).

Citations:
[91](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22900959/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  111. Bollard CM, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). T-cell therapy in the treatment of post-transplant lymphoproliferative disease. Nat Rev Clin Oncol. 2012 Sep; 9(9):510-9. PMID: [22801669](//www.ncbi.nlm.nih.gov/pubmed/22801669); PMCID: [PMC3743122](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3743122).

Citations:
[91](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22801669/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  112. Gerdemann U, Keirnan JM, Katari UL, Yanagisawa R, Christin AS, Huye LE, Perna SK, Ennamuri S, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol Ther. 2012 Aug; 20(8):1622-32. PMID: [22801446](//www.ncbi.nlm.nih.gov/pubmed/22801446); PMCID: [PMC3412490](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3412490).

Citations:
[107](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22801446/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  113. Chakraborty R, **Rooney C** , Dotti G, Savoldo B. Changes in chemokine receptor expression of regulatory T cells after ex vivo culture. J Immunother. 2012 May; 35(4):329-36. PMID: [22495390](//www.ncbi.nlm.nih.gov/pubmed/22495390); PMCID: [PMC3650839](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3650839).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22495390/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  114. White RE, Naresh KN, Meixlsperger S, Pinaud L, **Rooney C** , Savoldo B, Coutinho R, Gribben J, Ibrahim HA, Bower M, Nourse JP, Gandhi MK, Middeldorp J, Cader FZ, Murray P, Allday MJ, R?mer PC, B?d?r C, M?nz C. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest. 2012 Apr; 122(4):1487-502. PMID: [22406538](//www.ncbi.nlm.nih.gov/pubmed/22406538); PMCID: [PMC3314448](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3314448).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22406538/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  115. Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G. Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther. 2012 Feb; 20(2):246-9. PMID: [22297819](//www.ncbi.nlm.nih.gov/pubmed/22297819); PMCID: [PMC3277217](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3277217).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22297819/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  116. Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, [Powell SZ](https://profiles.viictr.org/profile/269823), Grossman R, Grada Z, [Scheurer ME](https://profiles.viictr.org/profile/265805), [Hegde M](https://profiles.viictr.org/profile/270076), [Leen AM](https://profiles.viictr.org/profile/268626), Bollard CM, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Ahmed N](https://profiles.viictr.org/profile/268944). Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother. 2012 Feb-Mar; 35(2):159-68. PMID: [22306904](//www.ncbi.nlm.nih.gov/pubmed/22306904); PMCID: [PMC3280423](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3280423).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22306904/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  117. Sili U, [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF, [Gee AP](https://profiles.viictr.org/profile/268378), Huls H, [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM, **Rooney CM**. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant. Cytotherapy. 2012 Jan; 14(1):7-11. PMID: [22172091](//www.ncbi.nlm.nih.gov/pubmed/22172091); PMCID: [PMC3705934](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3705934).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22172091/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  118. **Rooney CM**. Adoptive transfer of virus-directed T cells: will this fly for flu? Cytotherapy. 2012 Feb; 14(2):133-4. PMID: [22149160](//www.ncbi.nlm.nih.gov/pubmed/22149160).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22149160/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  119. Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, [Martinez C](https://profiles.viictr.org/profile/265827), Straathof K, Liu E, Durett AG, [Grilley B](https://profiles.viictr.org/profile/266987), [Liu H](https://profiles.viictr.org/profile/265543), Cruz CR, Savoldo B, [Gee AP](https://profiles.viictr.org/profile/268378), Schindler J, [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811), Spencer DM, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200). Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011 Nov 03; 365(18):1673-83. PMID: [22047558](//www.ncbi.nlm.nih.gov/pubmed/22047558); PMCID: [PMC3236370](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3236370).

Citations:
[654](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22047558/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  120. Muralidharan S, Hanley PJ, Liu E, Chakraborty R, Bollard C, [Shpall E](https://profiles.viictr.org/profile/12582631), **Rooney C** , Savoldo B, Rodgers J, Dotti G. Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes. J Immunol. 2011 Nov 15; 187(10):5221-32. PMID: [22013128](//www.ncbi.nlm.nih.gov/pubmed/22013128); PMCID: [PMC3208052](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3208052).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22013128/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  121. Shaffer DR, Sheehan AM, Yi Z, Rodgers CC, Bollard CM, [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181). Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection. Pediatr Blood Cancer. 2012 Oct; 59(4):758-61. PMID: [21994111](//www.ncbi.nlm.nih.gov/pubmed/21994111); PMCID: [PMC3258475](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3258475).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21994111/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCells

  122. Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, [Russell HV](https://profiles.viictr.org/profile/267675), Diouf O, Liu E, [Liu H](https://profiles.viictr.org/profile/265543), Wu MF, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200). Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood. 2011 Dec 01; 118(23):6050-6. PMID: [21984804](//www.ncbi.nlm.nih.gov/pubmed/21984804); PMCID: [PMC3234664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3234664).

Citations:
[490](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21984804/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  123. Gerdemann U, Katari U, Christin AS, Cruz CR, Tripic T, Rousseau A, [Gottschalk SM](https://profiles.viictr.org/profile/270181), Savoldo B, Vera JF, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Bollard CM, **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma. Mol Ther. 2011 Dec; 19(12):2258-68. PMID: [21915103](//www.ncbi.nlm.nih.gov/pubmed/21915103); PMCID: [PMC3242656](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3242656).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21915103/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  124. Cruz CR, Gerdemann U, [Leen AM](https://profiles.viictr.org/profile/268626), Shafer JA, Ku S, Tzou B, [Horton TM](https://profiles.viictr.org/profile/266755), Sheehan A, Copeland A, Younes A, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4. Clin Cancer Res. 2011 Nov 15; 17(22):7058-66. PMID: [21908573](//www.ncbi.nlm.nih.gov/pubmed/21908573); PMCID: [PMC3218253](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3218253).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21908573/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  125. Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, Wilson MH, Dotti G, **Rooney CM**. Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol Ther. 2011 Dec; 19(12):2239-48. PMID: [21878902](//www.ncbi.nlm.nih.gov/pubmed/21878902); PMCID: [PMC3242659](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3242659).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21878902/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  126. Nakazawa Y, Huye LE, Salsman VS, [Leen AM](https://profiles.viictr.org/profile/268626), [Ahmed N](https://profiles.viictr.org/profile/268944), [Rollins L](https://profiles.viictr.org/profile/28998998), Dotti G, [Gottschalk SM](https://profiles.viictr.org/profile/270181), Wilson MH, **Rooney CM**. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther. 2011 Dec; 19(12):2133-43. PMID: [21772253](//www.ncbi.nlm.nih.gov/pubmed/21772253); PMCID: [PMC3242651](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3242651).

Citations:
[62](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21772253/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  127. [Kamdar KY](https://profiles.viictr.org/profile/270282), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant. 2011 Jun; 16(3):274-80. PMID: [21467936](//www.ncbi.nlm.nih.gov/pubmed/21467936); PMCID: [PMC3167800](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3167800).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21467936/citedby/) Fields:

Tra Transplantation

Translation:Humans

  128. Gerdemann U, Vera JF, **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant. J Vis Exp. 2011 May 27; (51). PMID: [21654628](//www.ncbi.nlm.nih.gov/pubmed/21654628); PMCID: [PMC3197123](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3197123).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21654628/citedby/) Fields:

Bio BiologyMed Medicine (General)

Translation:HumansCells

  129. Hanley PJ, Shaffer DR, Cruz CR, Ku S, Tzou B, Liu H, Demmler-Harrison G, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181), Bollard CM. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation. Cytotherapy. 2011 Sep; 13(8):976-86. PMID: [21539497](//www.ncbi.nlm.nih.gov/pubmed/21539497); PMCID: [PMC3692015](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3692015).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21539497/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  130. Melcher A, Parato K, **Rooney CM** , Bell JC. Thunder and lightning: immunotherapy and oncolytic viruses collide. Mol Ther. 2011 Jun; 19(6):1008-16. PMID: [21505424](//www.ncbi.nlm.nih.gov/pubmed/21505424); PMCID: [PMC3129809](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3129809).

Citations:
[124](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21505424/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:Humans

  131. Savoldo B, [Ramos CA](https://profiles.viictr.org/profile/267038), Liu E, Mims MP, Keating MJ, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), Bollard CM, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), [Liu H](https://profiles.viictr.org/profile/265543), [Grilley B](https://profiles.viictr.org/profile/266987), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 2011 May; 121(5):1822-6. PMID: [21540550](//www.ncbi.nlm.nih.gov/pubmed/21540550); PMCID: [PMC3083795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3083795).

Citations:
[473](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21540550/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCells

  132. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181), Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, [El-Mallawany NK](https://profiles.viictr.org/profile/267714), Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49. PMID: [21454450](//www.ncbi.nlm.nih.gov/pubmed/21454450); PMCID: [PMC3112034](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3112034).

Citations:
[100](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21454450/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  133. Ngo MC, **Rooney CM** , Howard JM, [Heslop HE](https://profiles.viictr.org/profile/269811). Ex vivo gene transfer for improved adoptive immunotherapy of cancer. Hum Mol Genet. 2011 Apr 15; 20(R1):R93-9. PMID: [21415041](//www.ncbi.nlm.nih.gov/pubmed/21415041); PMCID: [PMC3095061](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3095061).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21415041/citedby/) Fields:

Gen GeneticsMol Molecular Biology

Translation:HumansAnimalsCells

  134. Bollard CM, [Gottschalk S](https://profiles.viictr.org/profile/270181), Helen Huls M, [Leen AM](https://profiles.viictr.org/profile/268626), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM**. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma. Cytotherapy. 2011 May; 13(5):518-22. PMID: [21361747](//www.ncbi.nlm.nih.gov/pubmed/21361747); PMCID: [PMC3186062](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3186062).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21361747/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  135. Quintarelli C, Dotti G, Hasan ST, De Angelis B, [Hoyos V](https://profiles.viictr.org/profile/23479202), Errichiello S, Mims M, Luciano L, Shafer J, [Leen AM](https://profiles.viictr.org/profile/268626), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Pane F, [Brenner MK](https://profiles.viictr.org/profile/268200), Savoldo B. High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells. Blood. 2011 Mar 24; 117(12):3353-62. PMID: [21278353](//www.ncbi.nlm.nih.gov/pubmed/21278353); PMCID: [PMC3069675](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3069675).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21278353/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  136. Turnis ME, **Rooney CM**. Enhancement of dendritic cells as vaccines for cancer. Immunotherapy. 2010 Nov; 2(6):847-62. PMID: [21091116](//www.ncbi.nlm.nih.gov/pubmed/21091116); PMCID: [PMC3433954](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3433954).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21091116/citedby/) Fields:

All Allergy and ImmunologyThe Therapeutics

Translation:HumansAnimalsCells

  137. Louis CU, Straathof K, Bollard CM, Ennamuri S, Gerken C, Lopez TT, Huls MH, Sheehan A, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), [Gee A](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181). Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010 Nov-Dec; 33(9):983-90. PMID: [20948438](//www.ncbi.nlm.nih.gov/pubmed/20948438); PMCID: [PMC2964409](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2964409).

Citations:
[86](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20948438/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  138. Song XT, Turnis ME, Zhou X, Zhu W, Hong BX, [Rollins L](https://profiles.viictr.org/profile/28998998), Rabinovich B, Chen SY, **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181). A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cells. Mol Ther. 2011 Jan; 19(1):211-7. PMID: [20959814](//www.ncbi.nlm.nih.gov/pubmed/20959814); PMCID: [PMC3017450](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3017450).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20959814/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:AnimalsCells

  139. Cruz CR, Hanley PJ, [Liu H](https://profiles.viictr.org/profile/265543), Torrano V, Lin YF, Arce JA, [Gottschalk S](https://profiles.viictr.org/profile/270181), Savoldo B, Dotti G, Louis CU, [Leen AM](https://profiles.viictr.org/profile/268626), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Bollard CM, [Heslop HE](https://profiles.viictr.org/profile/269811). Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience. Cytotherapy. 2010 Oct; 12(6):743-9. PMID: [20429793](//www.ncbi.nlm.nih.gov/pubmed/20429793); PMCID: [PMC2914831](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2914831).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20429793/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:Cells

  140. [Craddock JA](https://profiles.viictr.org/profile/27841637), Lu A, Bear A, Pule M, [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , Foster AE. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b. J Immunother. 2010 Oct; 33(8):780-8. PMID: [20842059](//www.ncbi.nlm.nih.gov/pubmed/20842059); PMCID: [PMC2998197](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2998197).

Citations:
[237](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20842059/citedby/)
Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  141. Sun J, Dotti G, Huye LE, Foster AE, Savoldo B, [Gramatges MM](https://profiles.viictr.org/profile/266349), Spencer DM, **Rooney CM**. T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanisms. Mol Ther. 2010 Nov; 18(11):2006-17. PMID: [20842106](//www.ncbi.nlm.nih.gov/pubmed/20842106); PMCID: [PMC2990520](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2990520).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20842106/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  142. Turnis ME, Song XT, Bear A, Foster AE, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), Chen SY, **Rooney CM**. IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity. J Immunol. 2010 Oct 01; 185(7):4223-32. PMID: [20817880](//www.ncbi.nlm.nih.gov/pubmed/20817880); PMCID: [PMC3153346](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3153346).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20817880/citedby/) Fields:

All Allergy and Immunology

Translation:AnimalsCells

  143. Shaffer DR, **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181). Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation. Immunotherapy. 2010 Sep; 2(5):663-71. PMID: [20874650](//www.ncbi.nlm.nih.gov/pubmed/20874650); PMCID: [PMC3075565](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3075565).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20874650/citedby/) Fields:

All Allergy and ImmunologyThe Therapeutics

Translation:HumansAnimalsCells

  144. Melenhorst JJ, [Leen AM](https://profiles.viictr.org/profile/268626), Bollard CM, Price DA, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Barrett AJ, [Heslop HE](https://profiles.viictr.org/profile/269811), Quigley MF. Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood. 2010 Nov 25; 116(22):4700-2. PMID: [20709906](//www.ncbi.nlm.nih.gov/pubmed/20709906); PMCID: [PMC2996125](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2996125).

Citations:
[76](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20709906/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  145. [Ramos CA](https://profiles.viictr.org/profile/267038), Asgari Z, Liu E, Yvon E, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells. 2010 Jun; 28(6):1107-15. PMID: [20506146](//www.ncbi.nlm.nih.gov/pubmed/20506146); PMCID: [PMC3290395](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3290395).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20506146/citedby/) Fields:

Cel Cell BiologyEmb Embryology

Translation:HumansAnimalsCells

  146. Stroncek D, Berlyne D, Fox B, [Gee A](https://profiles.viictr.org/profile/268378), Heimfeld S, Lindblad R, Loper K, McKenna D, **Rooney C** , Sabatino M, Wagner E, Whiteside T, Wood D, Heath-Mondoro T. Developments in clinical cell therapy. Cytotherapy. 2010 May; 12(3):425-8. PMID: [20078383](//www.ncbi.nlm.nih.gov/pubmed/20078383); PMCID: [PMC2946235](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2946235).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20078383/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  147. Shafer JA, Cruz CR, [Leen AM](https://profiles.viictr.org/profile/268626), Ku S, Lu A, Rousseau A, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM, Foster AE. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leuk Lymphoma. 2010 May; 51(5):870-80. PMID: [20367572](//www.ncbi.nlm.nih.gov/pubmed/20367572); PMCID: [PMC2991134](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2991134).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20367572/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  148. Hoyos V, Savoldo B, Quintarelli C, Mahendravada A, Zhang M, Vera J, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Brenner MK, Dotti G. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia. 2010 Jun; 24(6):1160-70. PMID: [20428207](//www.ncbi.nlm.nih.gov/pubmed/20428207); PMCID: [PMC2888148](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888148).

Citations:
[243](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20428207/citedby/)
Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimalsCells

  149. Vera JF, Brenner LJ, Gerdemann U, Ngo MC, Sili U, [Liu H](https://profiles.viictr.org/profile/265543), Wilson J, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), **Rooney CM**. Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother. 2010 Apr; 33(3):305-15. PMID: [20445351](//www.ncbi.nlm.nih.gov/pubmed/20445351); PMCID: [PMC2946348](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2946348).

Citations:
[76](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20445351/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  150. [Leen AM](https://profiles.viictr.org/profile/268626), Tripic T, **Rooney CM**. Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation. Expert Opin Biol Ther. 2010 Mar; 10(3):337-51. PMID: [20132056](//www.ncbi.nlm.nih.gov/pubmed/20132056); PMCID: [PMC2818535](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818535).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20132056/citedby/) Fields:

Bio BiologyThe Therapeutics

Translation:HumansCells

  151. Micklethwaite KP, Savoldo B, Hanley PJ, [Leen AM](https://profiles.viictr.org/profile/268626), Demmler-Harrison GJ, Cooper LJ, [Liu H](https://profiles.viictr.org/profile/265543), [Gee AP](https://profiles.viictr.org/profile/268378), [Shpall EJ](https://profiles.viictr.org/profile/12582631), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Bollard CM, Dotti G. Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood. 2010 Apr 01; 115(13):2695-703. PMID: [20110422](//www.ncbi.nlm.nih.gov/pubmed/20110422); PMCID: [PMC2852368](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852368).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20110422/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  152. [Heslop HE](https://profiles.viictr.org/profile/269811), Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, [Liu H](https://profiles.viictr.org/profile/265543), Wu MF, Rochester RJ, Amrolia PJ, Hurwitz JL, [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2010 Feb 04; 115(5):925-35. PMID: [19880495](//www.ncbi.nlm.nih.gov/pubmed/19880495); PMCID: [PMC2817637](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2817637).

Citations:
[331](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19880495/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  153. Galvan DL, Nakazawa Y, Kaja A, Kettlun C, Cooper LJ, **Rooney CM** , Wilson MH. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother. 2009 Oct; 32(8):837-44. PMID: [19752750](//www.ncbi.nlm.nih.gov/pubmed/19752750); PMCID: [PMC2796288](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2796288).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19752750/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  154. Nakazawa Y, Huye LE, Dotti G, Foster AE, Vera JF, Manuri PR, June CH, **Rooney CM** , Wilson MH. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother. 2009 Oct; 32(8):826-36. PMID: [19752751](//www.ncbi.nlm.nih.gov/pubmed/19752751); PMCID: [PMC2796278](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2796278).

Citations:
[59](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19752751/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  155. De Angelis B, Dotti G, Quintarelli C, Huye LE, Zhang L, Zhang M, Pane F, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , Savoldo B. Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). Blood. 2009 Nov 26; 114(23):4784-91. PMID: [19759356](//www.ncbi.nlm.nih.gov/pubmed/19759356); PMCID: [PMC2786289](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2786289).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19759356/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  156. Kaka AS, Shaffer DR, Hartmaier R, Hartmeier R, [Leen AM](https://profiles.viictr.org/profile/268626), Lu A, Bear A, **Rooney CM** , Foster AE. Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes. J Immunother. 2009 Sep; 32(7):726-36. PMID: [19561536](//www.ncbi.nlm.nih.gov/pubmed/19561536); PMCID: [PMC2790367](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2790367).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19561536/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  157. [Leen AM](https://profiles.viictr.org/profile/268626), Christin A, Myers GD, [Liu H](https://profiles.viictr.org/profile/265543), Cruz CR, Hanley PJ, Kennedy-Nasser AA, Leung KS, [Gee AP](https://profiles.viictr.org/profile/268378), [Krance RA](https://profiles.viictr.org/profile/268199), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 2009 Nov 05; 114(19):4283-92. PMID: [19700662](//www.ncbi.nlm.nih.gov/pubmed/19700662); PMCID: [PMC2774556](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2774556).

Citations:
[143](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19700662/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  158. Gerdemann U, Christin AS, Vera JF, [Ramos CA](https://profiles.viictr.org/profile/267038), Fujita Y, [Liu H](https://profiles.viictr.org/profile/265543), Dilloo D, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. Mol Ther. 2009 Sep; 17(9):1616-25. PMID: [19584818](//www.ncbi.nlm.nih.gov/pubmed/19584818); PMCID: [PMC2835253](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835253).

Citations:
[37](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19584818/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  159. [Ahmed N](https://profiles.viictr.org/profile/268944), Salsman VS, Yvon E, Louis CU, Perlaky L, Wels WS, Dishop MK, [Kleinerman EE](https://profiles.viictr.org/profile/12583249), Pule M, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181). Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol Ther. 2009 Oct; 17(10):1779-87. PMID: [19532139](//www.ncbi.nlm.nih.gov/pubmed/19532139); PMCID: [PMC2835000](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835000).

Citations:
[93](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19532139/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  160. Hanley PJ, Cruz CR, Savoldo B, [Leen AM](https://profiles.viictr.org/profile/268626), Stanojevic M, Khalil M, [Decker W](https://profiles.viictr.org/profile/267087), [Molldrem JJ](https://profiles.viictr.org/profile/12583319), [Liu H](https://profiles.viictr.org/profile/265543), [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, [Brenner MK](https://profiles.viictr.org/profile/268200), [Shpall EJ](https://profiles.viictr.org/profile/12582631), Bollard CM. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood. 2009 Aug 27; 114(9):1958-67. PMID: [19443656](//www.ncbi.nlm.nih.gov/pubmed/19443656); PMCID: [PMC2738578](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2738578).

Citations:
[98](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19443656/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  161. Di Stasi A, De Angelis B, **Rooney CM** , Zhang L, Mahendravada A, Foster AE, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G, Savoldo B. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 2009 Jun 18; 113(25):6392-402. PMID: [19377047](//www.ncbi.nlm.nih.gov/pubmed/19377047); PMCID: [PMC2710932](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2710932).

Citations:
[237](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19377047/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  162. Vera JF, [Hoyos V](https://profiles.viictr.org/profile/23479202), Savoldo B, Quintarelli C, Giordano Attianese GM, [Leen AM](https://profiles.viictr.org/profile/268626), [Liu H](https://profiles.viictr.org/profile/265543), Foster AE, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7. Mol Ther. 2009 May; 17(5):880-8. PMID: [19259067](//www.ncbi.nlm.nih.gov/pubmed/19259067); PMCID: [PMC2835146](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835146).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19259067/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  163. Reed W, Noga SJ, [Gee AP](https://profiles.viictr.org/profile/268378), **Rooney CM** , Wagner JE, McCullough J, McKenna DH, Whiteside TL, Donnenberg AD, Baker AK, Lindblad RW, Wagner EL, Mondoro TH. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion. 2009 Apr; 49(4):786-96. PMID: [19170985](//www.ncbi.nlm.nih.gov/pubmed/19170985); PMCID: [PMC4165072](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4165072).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19170985/citedby/) Fields:

Hem Hematology

Translation:Humans

  164. Pule MA, Savoldo B, Myers GD, Rossig C, [Russell HV](https://profiles.viictr.org/profile/267675), Dotti G, Huls MH, Liu E, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Yvon E, Weiss HL, [Liu H](https://profiles.viictr.org/profile/265543), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200). Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med. 2008 Nov; 14(11):1264-70. PMID: [18978797](//www.ncbi.nlm.nih.gov/pubmed/18978797); PMCID: [PMC2749734](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2749734).

Citations:
[579](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18978797/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCells

  165. Foster AE, Kwon S, Ke S, Lu A, Eldin K, Sevick-Muraca E, **Rooney CM**. In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt. 2008 Nov 01; 47(31):5944-52. PMID: [19122737](//www.ncbi.nlm.nih.gov/pubmed/19122737); PMCID: [PMC2744150](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2744150).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19122737/citedby/) Fields:

Oph Ophthalmology

Translation:HumansAnimalsCells

  166. Louis CU, Straathof K, Bollard CM, Gerken C, Huls MH, [Gresik MV](https://profiles.viictr.org/profile/269607), Wu MF, Weiss HL, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181). Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood. 2009 Mar 12; 113(11):2442-50. PMID: [18971421](//www.ncbi.nlm.nih.gov/pubmed/18971421); PMCID: [PMC2656271](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656271).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18971421/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  167. Fujita Y, [Leen AM](https://profiles.viictr.org/profile/268626), Sun J, Nakazawa Y, Yvon E, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy. J Immunother. 2008 Sep; 31(7):665-74. PMID: [18600178](//www.ncbi.nlm.nih.gov/pubmed/18600178); PMCID: [PMC2643068](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2643068).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18600178/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  168. Quintarelli C, Dotti G, De Angelis B, [Hoyos V](https://profiles.viictr.org/profile/23479202), Mims M, Luciano L, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Pane F, Savoldo B. Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Blood. 2008 Sep 01; 112(5):1876-85. PMID: [18591381](//www.ncbi.nlm.nih.gov/pubmed/18591381); PMCID: [PMC3401035](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3401035).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18591381/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  169. Foster AE, Dotti G, Lu A, Khalil M, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. J Immunother. 2008 Jun; 31(5):500-5. PMID: [18463534](//www.ncbi.nlm.nih.gov/pubmed/18463534); PMCID: [PMC2745436](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2745436).

Citations:
[117](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18463534/citedby/)
Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  170. Kaka AS, Foster AE, Weiss HL, **Rooney CM** , [Leen AM](https://profiles.viictr.org/profile/268626). Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale. J Immunother. 2008 May; 31(4):359-69. PMID: [18391760](//www.ncbi.nlm.nih.gov/pubmed/18391760); PMCID: [PMC2744357](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2744357).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18391760/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  171. de Witte MA, Jorritsma A, Swart E, Straathof KC, de Punder K, Haanen JB, **Rooney CM** , Schumacher TN. An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease. J Immunol. 2008 May 01; 180(9):6365-73. PMID: [18424760](//www.ncbi.nlm.nih.gov/pubmed/18424760).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18424760/citedby/) Fields:

All Allergy and Immunology

Translation:AnimalsCells

  172. Fujita Y, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant. 2008 Jan; 41(2):193-8. PMID: [17982497](//www.ncbi.nlm.nih.gov/pubmed/17982497).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17982497/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  173. [Leen AM](https://profiles.viictr.org/profile/268626), Christin A, Khalil M, Weiss H, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol. 2008 Jan; 82(1):546-54. PMID: [17942545](//www.ncbi.nlm.nih.gov/pubmed/17942545); PMCID: [PMC2224388](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2224388).

Citations:
[71](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17942545/citedby/) Fields:

Vir Virology

Translation:HumansCells

  174. Altvater B, Pscherer S, Eing BR, Kuehn J, **Rooney CM** , Juergens H, Rossig C, Landmeier S. Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function. Cancer Res. 2007 Sep 01; 67(17):8335-43. PMID: [17804749](//www.ncbi.nlm.nih.gov/pubmed/17804749).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17804749/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  175. Quintarelli C, Vera JF, Savoldo B, Giordano Attianese GM, Pule M, Foster AE, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. Blood. 2007 Oct 15; 110(8):2793-802. PMID: [17638856](//www.ncbi.nlm.nih.gov/pubmed/17638856); PMCID: [PMC2018664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2018664).

Citations:
[92](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17638856/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  176. Bollard CM, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Leen AM](https://profiles.viictr.org/profile/268626), Weiss H, Straathof KC, [Carrum G](https://profiles.viictr.org/profile/269657), Khalil M, Wu MF, Huls MH, Chang CC, [Gresik MV](https://profiles.viictr.org/profile/269607), [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. 2007 Oct 15; 110(8):2838-45. PMID: [17609424](//www.ncbi.nlm.nih.gov/pubmed/17609424); PMCID: [PMC2018666](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2018666).

Citations:
[157](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17609424/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  177. Kaka AS, **Rooney CM** , Savoldo B. What influence has B-cell depletion on viral infections? Leuk Lymphoma. 2007 Jul; 48(7):1257-8. PMID: [17613749](//www.ncbi.nlm.nih.gov/pubmed/17613749).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17613749/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  178. Foster AE, [Leen AM](https://profiles.viictr.org/profile/268626), Lee T, Okamura T, Lu A, Vera J, Atkinson R, Bollard CM, Dotti G, **Rooney CM**. Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12. J Immunother. 2007 Jul-Aug; 30(5):506-16. PMID: [17589291](//www.ncbi.nlm.nih.gov/pubmed/17589291).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17589291/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  179. [Ahmed N](https://profiles.viictr.org/profile/268944), Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, [Shine HD](https://profiles.viictr.org/profile/266899), Weiss HL, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gottschalk S](https://profiles.viictr.org/profile/270181). Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 2007 Jun 15; 67(12):5957-64. PMID: [17575166](//www.ncbi.nlm.nih.gov/pubmed/17575166).

Citations:
[85](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17575166/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  180. Tey SK, Dotti G, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200). Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation. Biol Blood Marrow Transplant. 2007 Aug; 13(8):913-24. PMID: [17640595](//www.ncbi.nlm.nih.gov/pubmed/17640595); PMCID: [PMC2040267](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2040267).

Citations:
[104](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17640595/citedby/)
Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  181. Savoldo B, **Rooney CM** , Di Stasi A, Abken H, Hombach A, Foster AE, Zhang L, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood. 2007 Oct 01; 110(7):2620-30. PMID: [17507664](//www.ncbi.nlm.nih.gov/pubmed/17507664); PMCID: [PMC1988944](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1988944).

Citations:
[114](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17507664/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  182. Myers GD, Bollard CM, Wu MF, Weiss H, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626). Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(11):677-86. PMID: [17417664](//www.ncbi.nlm.nih.gov/pubmed/17417664).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17417664/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  183. Seiler MP, [Gottschalk S](https://profiles.viictr.org/profile/270181), Cerullo V, Ratnayake M, Mane VP, Clarke C, Palmer DJ, [Ng P](https://profiles.viictr.org/profile/269950), **Rooney CM** , Lee B. Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates. Mol Ther. 2007 Feb; 15(2):386-92. PMID: [17235318](//www.ncbi.nlm.nih.gov/pubmed/17235318).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17235318/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  184. [Leen A](https://profiles.viictr.org/profile/268626), Ratnayake M, Foster A, Heym K, [Ahmed N](https://profiles.viictr.org/profile/268944), **Rooney CM** , [Gottschalk S](https://profiles.viictr.org/profile/270181). Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells. J Immunother. 2007 Jan; 30(1):96-107. PMID: [17198088](//www.ncbi.nlm.nih.gov/pubmed/17198088).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17198088/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  185. [Leen AM](https://profiles.viictr.org/profile/268626), **Rooney CM** , Foster AE. Improving T cell therapy for cancer. Annu Rev Immunol. 2007; 25:243-65. PMID: [17129181](//www.ncbi.nlm.nih.gov/pubmed/17129181).

Citations:
[107](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17129181/citedby/)
Fields:

All Allergy and Immunology

Translation:HumansAnimalsCells

  186. Lee TC, Goss JA, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Barshes NR](https://profiles.viictr.org/profile/269878), Caldwell YM, [Gee AP](https://profiles.viictr.org/profile/268378), Scott JD, Savoldo B. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant. 2006 Nov-Dec; 20(6):689-94. PMID: [17100717](//www.ncbi.nlm.nih.gov/pubmed/17100717).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17100717/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  187. [Leen AM](https://profiles.viictr.org/profile/268626), Myers GD, Sili U, Huls MH, Weiss H, Leung KS, [Carrum G](https://profiles.viictr.org/profile/269657), [Krance RA](https://profiles.viictr.org/profile/268199), Chang CC, [Molldrem JJ](https://profiles.viictr.org/profile/12583319), [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006 Oct; 12(10):1160-6. PMID: [16998485](//www.ncbi.nlm.nih.gov/pubmed/16998485).

Citations:
[254](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16998485/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCells

  188. Vera J, Savoldo B, Vigouroux S, Biagi E, Pule M, Rossig C, Wu J, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells. Blood. 2006 Dec 01; 108(12):3890-7. PMID: [16926291](//www.ncbi.nlm.nih.gov/pubmed/16926291); PMCID: [PMC1895462](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895462).

Citations:
[152](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16926291/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  189. Savoldo B, Goss JA, Hammer MM, Zhang L, Lopez T, [Gee AP](https://profiles.viictr.org/profile/268378), Lin YF, Quiros-Tejeira RE, Reinke P, Schubert S, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Finegold MJ](https://profiles.viictr.org/profile/269596), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood. 2006 Nov 01; 108(9):2942-9. PMID: [16835376](//www.ncbi.nlm.nih.gov/pubmed/16835376); PMCID: [PMC1895521](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895521).

Citations:
[84](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16835376/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  190. Kennedy-Nasser AA, Bollard CM, **Rooney CM**. Adoptive immunotherapy for Hodgkin's lymphoma. Int J Hematol. 2006 Jun; 83(5):385-90. PMID: [16787867](//www.ncbi.nlm.nih.gov/pubmed/16787867).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16787867/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  191. Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, **Rooney CM** , Karpen SJ, Wyllie S. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation. Transpl Infect Dis. 2006 Jun; 8(2):108-12. PMID: [16734634](//www.ncbi.nlm.nih.gov/pubmed/16734634).

Citations:  Fields:

Tra Transplantation

Translation:Humans

  192. Lacuesta K, Buza E, Hauser H, Granville L, Pule M, Corboy G, [Finegold M](https://profiles.viictr.org/profile/269596), Weiss H, Chen SY, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor. J Immunother. 2006 May-Jun; 29(3):250-60. PMID: [16699368](//www.ncbi.nlm.nih.gov/pubmed/16699368).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16699368/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  193. Lee TC, Savoldo B, [Barshes NR](https://profiles.viictr.org/profile/269878), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gee AP](https://profiles.viictr.org/profile/268378), Caldwell Y, Scott JD, Goss JA. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant. 2006 May-Jun; 20(3):389-93. PMID: [16824159](//www.ncbi.nlm.nih.gov/pubmed/16824159).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16824159/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  194. Bollard CM, [Gottschalk S](https://profiles.viictr.org/profile/270181), Huls MH, [Molldrem J](https://profiles.viictr.org/profile/12583319), Przepiorka D, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma. 2006 May; 47(5):837-42. PMID: [16753867](//www.ncbi.nlm.nih.gov/pubmed/16753867).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16753867/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  195. [Leen AM](https://profiles.viictr.org/profile/268626), Bollard CM, Myers GD, **Rooney CM**. Adenoviral infections in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 Mar; 12(3):243-51. PMID: [16503493](//www.ncbi.nlm.nih.gov/pubmed/16503493).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16503493/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  196. Foster AE, **Rooney CM**. Improving T cell therapy for cancer. Expert Opin Biol Ther. 2006 Mar; 6(3):215-29. PMID: [16503732](//www.ncbi.nlm.nih.gov/pubmed/16503732).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16503732/citedby/) Fields:

Bio BiologyThe Therapeutics

Translation:HumansAnimalsCells

  197. [Gottschalk S](https://profiles.viictr.org/profile/270181), Bollard CM, Straathof KC, Louis CU, Savoldo B, Dotti G, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. T cell therapies. Ernst Schering Found Symp Proc. 2006; (4):69-82. PMID: [17824182](//www.ncbi.nlm.nih.gov/pubmed/17824182).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17824182/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  198. Pscherer S, Altvater B, Pule M, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Vormoor J, Rossig C, B?r A, J?rgens H. Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors. J Immunother. 2006 Jan-Feb; 29(1):21-31. PMID: [16365597](//www.ncbi.nlm.nih.gov/pubmed/16365597).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16365597/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  199. Bollard CM, Huls MH, Buza E, Weiss H, Torrano V, [Gresik MV](https://profiles.viictr.org/profile/269607), Chang J, [Gee A](https://profiles.viictr.org/profile/268378), [Gottschalk SM](https://profiles.viictr.org/profile/270181), [Carrum G](https://profiles.viictr.org/profile/269657), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma. Clin Lymphoma Myeloma. 2006 Jan; 6(4):342-7. PMID: [16507214](//www.ncbi.nlm.nih.gov/pubmed/16507214).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16507214/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  200. [Leen AM](https://profiles.viictr.org/profile/268626), Myers GD, Bollard CM, Huls MH, Sili U, [Gee AP](https://profiles.viictr.org/profile/268378), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Ann N Y Acad Sci. 2005 Dec; 1062:104-15. PMID: [16461793](//www.ncbi.nlm.nih.gov/pubmed/16461793).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16461793/citedby/) Fields:

Sci Science

Translation:HumansCells

  201. **Rooney CM**. Hitchhiker's guide to the T cell. Nat Med. 2005 Oct; 11(10):1051-2. PMID: [16211037](//www.ncbi.nlm.nih.gov/pubmed/16211037).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16211037/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansAnimalsCells

  202. Straathof KC, [Leen AM](https://profiles.viictr.org/profile/268626), Buza EL, Taylor G, Huls MH, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Bollard CM. Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma. J Immunol. 2005 Sep 15; 175(6):4137-47. PMID: [16148164](//www.ncbi.nlm.nih.gov/pubmed/16148164).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16148164/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  203. Lee TC, Savoldo B, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Gee AP](https://profiles.viictr.org/profile/268378), Caldwell Y, [Barshes NR](https://profiles.viictr.org/profile/269878), Scott JD, Bristow LJ, [O'Mahony CA](https://profiles.viictr.org/profile/267872), Goss JA. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant. 2005 Sep; 5(9):2222-8. PMID: [16095501](//www.ncbi.nlm.nih.gov/pubmed/16095501).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16095501/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  204. Meyer S, Brestrich G, Moosmann A, Kern F, Tesfa L, Babel N, Mittenzweig A, **Rooney CM** , Hammerschmidt W, Volk HD, Reinke P, Hammer MH. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy. Eur J Immunol. 2005 Jul; 35(7):2250-8. PMID: [15915543](//www.ncbi.nlm.nih.gov/pubmed/15915543).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15915543/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  205. Straathof KC, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Pul? MA. A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther. 2005 Nov; 12(5):933-41. PMID: [15979412](//www.ncbi.nlm.nih.gov/pubmed/15979412).

Citations:
[223](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15979412/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  206. Savoldo B, **Rooney CM** , Quiros-Tejeira RE, Caldwell Y, Wagner HJ, Lee T, [Finegold MJ](https://profiles.viictr.org/profile/269596), Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), Goss JA. Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am J Transplant. 2005 Mar; 5(3):566-72. PMID: [15707412](//www.ncbi.nlm.nih.gov/pubmed/15707412).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15707412/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  207. Straathof KC, Yotnda P, Dotti G, Vanin EF, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Spencer DM, **Rooney CM** , Pul? MA. An inducible caspase 9 safety switch for T-cell therapy. Blood. 2005 Jun 01; 105(11):4247-54. PMID: [15728125](//www.ncbi.nlm.nih.gov/pubmed/15728125); PMCID: [PMC1895037](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895037).

Citations:
[297](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15728125/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  208. Dotti G, Savoldo B, Pule M, Straathof KC, Biagi E, Yvon E, Vigouroux S, [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood. 2005 Jun 15; 105(12):4677-84. PMID: [15713795](//www.ncbi.nlm.nih.gov/pubmed/15713795); PMCID: [PMC1895003](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895003).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15713795/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  209. [Gottschalk S](https://profiles.viictr.org/profile/270181), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Post-transplant lymphoproliferative disorders. Annu Rev Med. 2005; 56:29-44. PMID: [15660500](//www.ncbi.nlm.nih.gov/pubmed/15660500).

Citations:
[132](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15660500/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCells

  210. [Gottschalk S](https://profiles.viictr.org/profile/270181), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Adoptive immunotherapy for EBV-associated malignancies. Leuk Lymphoma. 2005 Jan; 46(1):1-10. PMID: [15621775](//www.ncbi.nlm.nih.gov/pubmed/15621775).

Citations:
[43](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15621775/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  211. [Leen AM](https://profiles.viictr.org/profile/268626), **Rooney CM**. Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol. 2005 Jan; 128(2):135-44. PMID: [15638847](//www.ncbi.nlm.nih.gov/pubmed/15638847).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15638847/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  212. Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, [Gresik MV](https://profiles.viictr.org/profile/269607), [Carrum G](https://profiles.viictr.org/profile/269657), Hudson M, Dilloo D, [Gee A](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med. 2004 Dec 20; 200(12):1623-33. PMID: [15611290](//www.ncbi.nlm.nih.gov/pubmed/15611290); PMCID: [PMC2211993](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2211993).

Citations:
[131](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15611290/citedby/)
Fields:

All Allergy and ImmunologyMed Medicine (General)

Translation:HumansCells

  213. McCullough J, Wagner J, Key N, [Gee A](https://profiles.viictr.org/profile/268378), **Rooney C** , Whiteside T, Donnenberg A, Lindblad R. Production assistance for cellular therapies. Transfusion. 2004 Dec; 44(12):1793-5. PMID: [15584997](//www.ncbi.nlm.nih.gov/pubmed/15584997).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15584997/citedby/) Fields:

Hem Hematology

Translation:Humans

  214. Straathof KC, Bollard CM, [Popat U](https://profiles.viictr.org/profile/12583693), Huls MH, Lopez T, Morriss MC, [Gresik MV](https://profiles.viictr.org/profile/269607), [Gee AP](https://profiles.viictr.org/profile/268378), [Russell HV](https://profiles.viictr.org/profile/267675), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. Blood. 2005 Mar 01; 105(5):1898-904. PMID: [15542583](//www.ncbi.nlm.nih.gov/pubmed/15542583).

Citations:
[128](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15542583/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  215. Foster AE, Bradstock KF, Sili U, Marangolo M, **Rooney CM** , Gottlieb DJ. A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors. Biol Blood Marrow Transplant. 2004 Nov; 10(11):761-71. PMID: [15505607](//www.ncbi.nlm.nih.gov/pubmed/15505607).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15505607/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  216. Pakakasama S, Eames GM, Morriss MC, Huls MH, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Krance RA](https://profiles.viictr.org/profile/268199). Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes. Transplantation. 2004 Sep 15; 78(5):755-7. PMID: [15371682](//www.ncbi.nlm.nih.gov/pubmed/15371682).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15371682/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  217. [Heslop HE](https://profiles.viictr.org/profile/269811), Savoldo B, **Rooney CM**. Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease. Best Pract Res Clin Haematol. 2004 Sep; 17(3):401-13. PMID: [15498712](//www.ncbi.nlm.nih.gov/pubmed/15498712).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15498712/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  218. [Leen AM](https://profiles.viictr.org/profile/268626), Sili U, Vanin EF, Jewell AM, Xie W, Vignali D, [Piedra PA](https://profiles.viictr.org/profile/268114), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood. 2004 Oct 15; 104(8):2432-40. PMID: [15265797](//www.ncbi.nlm.nih.gov/pubmed/15265797).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15265797/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  219. [Heslop HE](https://profiles.viictr.org/profile/269811), Gottschalk SM, Bollard CM, Straathof KC, Huls MH, Brenner MK, **Rooney CM**. Options for T-cell based therapies. Vox Sang. 2004 Jul; 87 Suppl 2:230-4. PMID: [15209923](//www.ncbi.nlm.nih.gov/pubmed/15209923).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  220. Bollard CM, Straathof KC, Huls MH, [Leen A](https://profiles.viictr.org/profile/268626), Lacuesta K, Davis A, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease. J Immunother. 2004 Jul-Aug; 27(4):317-27. PMID: [15235393](//www.ncbi.nlm.nih.gov/pubmed/15235393).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15235393/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  221. Yotnda P, Savoldo B, Charlet-Berguerand N, **Rooney C** , [Brenner M](https://profiles.viictr.org/profile/268200). Targeted delivery of adenoviral vectors by cytotoxic T cells. Blood. 2004 Oct 15; 104(8):2272-80. PMID: [15161664](//www.ncbi.nlm.nih.gov/pubmed/15161664).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15161664/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  222. Bollard CM, Kuehnle I, [Leen A](https://profiles.viictr.org/profile/268626), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant. 2004 Mar; 10(3):143-55. PMID: [14993880](//www.ncbi.nlm.nih.gov/pubmed/14993880).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14993880/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  223. Voo KS, Fu T, Wang HY, Tellam J, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , Wang RF. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med. 2004 Feb 16; 199(4):459-70. PMID: [14769850](//www.ncbi.nlm.nih.gov/pubmed/14769850); PMCID: [PMC2211826](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2211826).

Citations:
[62](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14769850/citedby/) Fields:

All Allergy and ImmunologyMed Medicine (General)

Translation:HumansCells

  224. Wagner HJ, Bollard CM, Huls MH, Anderson R, Prentice HG, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Vigouroux S. A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells. Cancer Gene Ther. 2004 Feb; 11(2):81-91. PMID: [14685154](//www.ncbi.nlm.nih.gov/pubmed/14685154).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14685154/citedby/) Fields:

Gen GeneticsNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  225. Wagner HJ, Cheng YC, Huls MH, [Gee AP](https://profiles.viictr.org/profile/268378), Kuehnle I, [Krance RA](https://profiles.viictr.org/profile/268199), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood. 2004 May 15; 103(10):3979-81. PMID: [14751931](//www.ncbi.nlm.nih.gov/pubmed/14751931).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14751931/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  226. Schroers R, Shen L, [Rollins L](https://profiles.viictr.org/profile/28998998), **Rooney CM** , Slawin K, Sonderstrup G, Huang XF, Chen SY. Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes. Clin Cancer Res. 2003 Oct 15; 9(13):4743-55. PMID: [14581345](//www.ncbi.nlm.nih.gov/pubmed/14581345).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14581345/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  227. [Leen AM](https://profiles.viictr.org/profile/268626), Sili U, Savoldo B, Jewell AM, [Piedra PA](https://profiles.viictr.org/profile/268114), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM**. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood. 2004 Feb 01; 103(3):1011-9. PMID: [14525768](//www.ncbi.nlm.nih.gov/pubmed/14525768).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14525768/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  228. Yvon E, Wagner HJ, Biagi E, Dotti G, Sili U, Lira C, **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200), Vigouroux S. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J Virol. 2003 Oct; 77(20):10872-80. PMID: [14512537](//www.ncbi.nlm.nih.gov/pubmed/14512537); PMCID: [PMC224961](//www.ncbi.nlm.nih.gov/pmc/articles/PMC224961).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14512537/citedby/) Fields:

Vir Virology

Translation:HumansCells

  229. Amrolia PJ, Muccioli-Casadei G, Yvon E, Huls H, Sili U, Wieder ED, Bollard C, Michalek J, Ghetie V, [Heslop HE](https://profiles.viictr.org/profile/269811), [Molldrem JJ](https://profiles.viictr.org/profile/12583319), **Rooney CM** , Schlinder J, Vitetta E, [Brenner MK](https://profiles.viictr.org/profile/268200). Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood. 2003 Sep 15; 102(6):2292-9. PMID: [12763937](//www.ncbi.nlm.nih.gov/pubmed/12763937).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12763937/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  230. Schroers R, **Rooney CM** , Gahn B, Chen SY, Kr?ger S. Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1. J Immunother. 2003 May-Jun; 26(3):212-21. PMID: [12806275](//www.ncbi.nlm.nih.gov/pubmed/12806275).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12806275/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  231. Sili U, Huls MH, Davis AR, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J Immunother. 2003 May-Jun; 26(3):241-56. PMID: [12806278](//www.ncbi.nlm.nih.gov/pubmed/12806278).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12806278/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCells

  232. [Ling PD](https://profiles.viictr.org/profile/268320), Lednicky JA, [Keitel WA](https://profiles.viictr.org/profile/267970), Poston DG, White ZS, Peng R, Liu Z, Mehta SK, Pierson DL, **Rooney CM** , Vilchez RA, [Smith EO](https://profiles.viictr.org/profile/269617), [Butel JS](https://profiles.viictr.org/profile/266408). The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003 May 15; 187(10):1571-80. PMID: [12721937](//www.ncbi.nlm.nih.gov/pubmed/12721937).

Citations:
[59](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12721937/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCells

  233. Huls MH, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease. Acta Haematol. 2003; 110(2-3):149-53. PMID: [14583675](//www.ncbi.nlm.nih.gov/pubmed/14583675).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  234. Wagner HJ, Sili U, Gahn B, Vigouroux S, Huls MH, Xie W, Vignali D, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15. Cytotherapy. 2003; 5(3):231-40. PMID: [12850791](//www.ncbi.nlm.nih.gov/pubmed/12850791).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12850791/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  235. Bollard CM, Savoldo B, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease. Acta Haematol. 2003; 110(2-3):139-48. PMID: [14583674](//www.ncbi.nlm.nih.gov/pubmed/14583674).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14583674/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  236. Straathof KC, Spencer DM, Sutton RE, **Rooney CM**. Suicide genes as safety switches in T lymphocytes. Cytotherapy. 2003; 5(3):227-30. PMID: [12850790](//www.ncbi.nlm.nih.gov/pubmed/12850790).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12850790/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  237. Straathof KC, Bollard CM, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist. 2003; 8(1):83-98. PMID: [12604735](//www.ncbi.nlm.nih.gov/pubmed/12604735).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12604735/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  238. Voo KS, Fu T, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), **Rooney CM** , Wang RF. Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. Cancer Res. 2002 Dec 15; 62(24):7195-9. PMID: [12499257](//www.ncbi.nlm.nih.gov/pubmed/12499257).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12499257/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  239. [Gottschalk S](https://profiles.viictr.org/profile/270181), Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood. 2003 Mar 01; 101(5):1905-12. PMID: [12411306](//www.ncbi.nlm.nih.gov/pubmed/12411306).

Citations:
[69](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12411306/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  240. Straathof KC, Savoldo B, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Immunotherapy for post-transplant lymphoproliferative disease. Br J Haematol. 2002 Sep; 118(3):728-40. PMID: [12181039](//www.ncbi.nlm.nih.gov/pubmed/12181039).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12181039/citedby/) Fields:

Hem Hematology

Translation:Humans

  241. Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood. 2002 Dec 01; 100(12):4059-66. PMID: [12393655](//www.ncbi.nlm.nih.gov/pubmed/12393655).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12393655/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  242. Bollard CM, Calonge MJ, Huls MH, Wagner HJ, Massague J, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , R?ssig C. Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity. Blood. 2002 May 01; 99(9):3179-87. PMID: [11964281](//www.ncbi.nlm.nih.gov/pubmed/11964281).

Citations:
[160](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11964281/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  243. Rossig C, Bollard CM, [Nuchtern JG](https://profiles.viictr.org/profile/266271), **Rooney CM** , [Brenner MK](https://profiles.viictr.org/profile/268200). Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy. Blood. 2002 Mar 15; 99(6):2009-16. PMID: [11877273](//www.ncbi.nlm.nih.gov/pubmed/11877273).

Citations:
[78](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11877273/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  244. Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, [Gee AP](https://profiles.viictr.org/profile/268378), [Ling PD](https://profiles.viictr.org/profile/268320), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002 Jan 15; 168(2):909-18. PMID: [11777989](//www.ncbi.nlm.nih.gov/pubmed/11777989).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11777989/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  245. [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM, Gottschalk S, Kuehnle I, Huls MH, [Gee AP](https://profiles.viictr.org/profile/268378), Brenner MK, **Rooney CM**. Immune therapy for EBV infections after hemopoietic stem-cell transplant. Cytotherapy. 2002; 4(5):433-4. PMID: [12473214](//www.ncbi.nlm.nih.gov/pubmed/12473214).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12473214/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:HumansCells

  246. Gahn B, [Hunt G](https://profiles.viictr.org/profile/37847468), **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Immunotherapy to reconstitute immunity to DNA viruses. Semin Hematol. 2002 Jan; 39(1):41-7. PMID: [11799528](//www.ncbi.nlm.nih.gov/pubmed/11799528).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11799528/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  247. **Rooney CM** , Bollard C, Huls MH, Gahn B, [Gottschalk S](https://profiles.viictr.org/profile/270181), Wagner HJ, Anderson R, Prentice HG, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Immunotherapy for Hodgkin's disease. Ann Hematol. 2002; 81 Suppl 2:S39-42. PMID: [12611071](//www.ncbi.nlm.nih.gov/pubmed/12611071).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12611071/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  248. Scherer SP, Baer A, Vormoor J, **Rooney CM** , Brenner MK, Juergens H, Roessig C. Targeting CD19 with genetically modified EBV-specific human T lymphocytes. Ann Hematol. 2002; 81 Suppl 2:S42-3. PMID: [12611072](//www.ncbi.nlm.nih.gov/pubmed/12611072).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12611072/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  249. Liu Z, Savoldo B, Huls H, Lopez T, [Gee A](https://profiles.viictr.org/profile/268378), Wilson J, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas. Recent Results Cancer Res. 2002; 159:123-33. PMID: [11785836](//www.ncbi.nlm.nih.gov/pubmed/11785836).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11785836/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  250. Wagner HJ, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2002; 8(1):1-8. PMID: [11846351](//www.ncbi.nlm.nih.gov/pubmed/11846351).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11846351/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:Humans

  251. Savoldo B, Goss J, Liu Z, Huls MH, Doster S, [Gee AP](https://profiles.viictr.org/profile/268378), Brenner MK, Heslop HE, **Rooney CM**. Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation. 2001 Sep 27; 72(6):1078-86. PMID: [11579304](//www.ncbi.nlm.nih.gov/pubmed/11579304).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11579304/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  252. Gahn B, Siller-Lopez F, Pirooz AD, Yvon E, Gottschalk S, Longnecker R, Brenner MK, Heslop HE, Aguilar-Cordova E, **Rooney CM**. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma. Int J Cancer. 2001 Sep 01; 93(5):706-13. PMID: [11477583](//www.ncbi.nlm.nih.gov/pubmed/11477583).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11477583/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  253. Dotti G, Savoldo B, Takahashi S, Goltsova T, Brown M, Rill D, **Rooney C** , Brenner M. Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy. Exp Hematol. 2001 Aug; 29(8):952-61. PMID: [11495701](//www.ncbi.nlm.nih.gov/pubmed/11495701).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11495701/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  254. Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood. 2001 Feb 15; 97(4):835-43. PMID: [11159505](//www.ncbi.nlm.nih.gov/pubmed/11159505).

Citations:
[98](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11159505/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  255. Hong R, Shen V, **Rooney C** , Hughes DP, Smith C, Comoli P, Zhang L. Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes. Clin Immunol. 2001 Jan; 98(1):54-61. PMID: [11141327](//www.ncbi.nlm.nih.gov/pubmed/11141327).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11141327/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  256. **Rooney CM** , Aguilar LK, Huls MH, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines. Curr Top Microbiol Immunol. 2001; 258:221-9. PMID: [11443864](//www.ncbi.nlm.nih.gov/pubmed/11443864).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11443864/citedby/) Fields:

All Allergy and ImmunologyMic Microbiology

Translation:HumansCells

  257. Savoldo B, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients. Leuk Lymphoma. 2000 Nov; 39(5-6):455-64. PMID: [11342329](//www.ncbi.nlm.nih.gov/pubmed/11342329).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11342329/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  258. You Z, Huang XF, Hester J, Rollins L, **Rooney C** , Chen SY. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway. J Immunol. 2000 Oct 15; 165(8):4581-91. PMID: [11035100](//www.ncbi.nlm.nih.gov/pubmed/11035100).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11035100/citedby/) Fields:

All Allergy and Immunology

Translation:AnimalsCells

  259. [Heslop H](https://profiles.viictr.org/profile/269811), **Rooney C** , Brenner M, [Krance R](https://profiles.viictr.org/profile/268199), [Carrum G](https://profiles.viictr.org/profile/269657), Gahn B, Bollard C, Khan S, [Gee A](https://profiles.viictr.org/profile/268378), [Popat U](https://profiles.viictr.org/profile/12583693), Gresik M, Przepiorka D, Kuehnle I, [Grilley B](https://profiles.viictr.org/profile/266987). Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000 Jul 01; 11(10):1465-75. PMID: [10910143](//www.ncbi.nlm.nih.gov/pubmed/10910143).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10910143/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  260. Kuehnle I, Huls MH, Liu Z, Semmelmann M, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 2000 Feb 15; 95(4):1502-5. PMID: [10666232](//www.ncbi.nlm.nih.gov/pubmed/10666232).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10666232/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  261. Schroers R, Sinha I, Segall H, Schmidt-Wolf IG, **Rooney CM** , Brenner MK, Sutton RE, Chen SY. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther. 2000 Feb; 1(2):171-9. PMID: [10933928](//www.ncbi.nlm.nih.gov/pubmed/10933928).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10933928/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  262. Roskrow MA, Dilloo D, Suzuki N, Zhong W, **Rooney CM** , Brenner MK. Autoimmune disease induced by dendritic cell immunization against leukemia. Leuk Res. 1999 Jun; 23(6):549-57. PMID: [10374848](//www.ncbi.nlm.nih.gov/pubmed/10374848).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10374848/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCellsPHPublic Health

  263. Aguilar LK, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811). Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation. Curr Opin Oncol. 1999 Mar; 11(2):96-101. PMID: [10188073](//www.ncbi.nlm.nih.gov/pubmed/10188073).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10188073/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  264. [Heslop HE](https://profiles.viictr.org/profile/269811), Perez M, Benaim E, Rochester R, Brenner MK, **Rooney CM**. Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant. J Clin Apher. 1999; 14(3):154-6. PMID: [10540372](//www.ncbi.nlm.nih.gov/pubmed/10540372).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10540372/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  265. **Rooney CM** , Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998 Sep 01; 92(5):1549-55. PMID: [9716582](//www.ncbi.nlm.nih.gov/pubmed/9716582).

Citations:
[273](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9716582/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  266. Smith CA, Woodruff LS, **Rooney C** , Kitchingman GR. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum Gene Ther. 1998 Jul 01; 9(10):1419-27. PMID: [9681413](//www.ncbi.nlm.nih.gov/pubmed/9681413).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9681413/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCells

  267. Kitchingman GR, **Rooney C**. Cytotoxic T cells and immunotherapy. Pediatr Radiol. 1998 Jul; 28(7):489-91. PMID: [9662564](//www.ncbi.nlm.nih.gov/pubmed/9662564).

Citations:  Fields:

Ped PediatricsRad RadiologyRad Radiotherapy

Translation:HumansCells

  268. Roskrow MA, **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, [Krance RA](https://profiles.viictr.org/profile/268199), Gresik MV, [McClain K](https://profiles.viictr.org/profile/266880), Aguilar LK, [Grilley B](https://profiles.viictr.org/profile/266987), Rob E, [Carrum G](https://profiles.viictr.org/profile/269657). Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 1998 May 20; 9(8):1237-50. PMID: [9625264](//www.ncbi.nlm.nih.gov/pubmed/9625264).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9625264/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  269. Roskrow MA, Suzuki N, Gan Yj, Sixbey JW, Ng CY, Kimbrough S, Hudson M, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood. 1998 Apr 15; 91(8):2925-34. PMID: [9531603](//www.ncbi.nlm.nih.gov/pubmed/9531603).

Citations:
[70](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9531603/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  270. **Rooney CM** , Roskrow MA, Smith CA, Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Immunotherapy for Epstein-Barr virus-associated cancers. J Natl Cancer Inst Monogr. 1998; (23):89-93. PMID: [9709309](//www.ncbi.nlm.nih.gov/pubmed/9709309).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9709309/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  271. **Rooney CM** , [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK. EBV specific CTL: a model for immune therapy. Vox Sang. 1998; 74 Suppl 2:497-8. PMID: [9704488](//www.ncbi.nlm.nih.gov/pubmed/9704488).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9704488/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  272. **Rooney CM** , Roskrow MA, Suzuki N, Ng CY, Brenner MK, [Heslop H](https://profiles.viictr.org/profile/269811). Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells. Ann Oncol. 1998; 9 Suppl 5:S129-32. PMID: [9926252](//www.ncbi.nlm.nih.gov/pubmed/9926252).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9926252/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  273. Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Gene and cell transfer for specific immunotherapy. Vox Sang. 1998; 74 Suppl 2:87-90. PMID: [9704428](//www.ncbi.nlm.nih.gov/pubmed/9704428).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  274. Tanner JE, Diaz-Mitoma F, **Rooney CM** , Alfieri C. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J Infect Dis. 1997 Dec; 176(6):1454-61. PMID: [9395354](//www.ncbi.nlm.nih.gov/pubmed/9395354).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9395354/citedby/) Fields:

Com Communicable Diseases

Translation:HumansAnimalsCells

  275. [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM**. Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev. 1997 Jun; 157:217-22. PMID: [9255632](//www.ncbi.nlm.nih.gov/pubmed/9255632).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9255632/citedby/) Fields:

All Allergy and ImmunologyTra Transplantation

Translation:HumansCells

  276. **Rooney CM** , Smith CA, [Heslop HE](https://profiles.viictr.org/profile/269811). Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity. Mol Med Today. 1997 Jan; 3(1):24-30. PMID: [9021739](//www.ncbi.nlm.nih.gov/pubmed/9021739).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9021739/citedby/) Fields:

Mol Molecular Biology

Translation:HumansAnimalsCells

  277. Smith CA, Woodruff LS, Kitchingman GR, **Rooney CM**. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol. 1996 Oct; 70(10):6733-40. PMID: [8794310](//www.ncbi.nlm.nih.gov/pubmed/8794310); PMCID: [PMC190716](//www.ncbi.nlm.nih.gov/pmc/articles/PMC190716).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8794310/citedby/) Fields:

Vir Virology

Translation:HumansCells

  278. Smith CA, Ng CY, Loftin SK, Li C, [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, **Rooney CM**. Adoptive immunotherapy for Epstein-Barr virus-related lymphoma. Leuk Lymphoma. 1996 Oct; 23(3-4):213-20. PMID: [9031101](//www.ncbi.nlm.nih.gov/pubmed/9031101).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9031101/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  279. Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), Rill D, Li C, Smith C, [Krance R](https://profiles.viictr.org/profile/268199), **Rooney C**. Transfer of marker genes into hemopoietic progenitor cells. Cytokines Mol Ther. 1996 Sep; 2(3):193-200. PMID: [9384704](//www.ncbi.nlm.nih.gov/pubmed/9384704).

Citations:  Fields:

All Allergy and ImmunologyMol Molecular Biology

Translation:HumansCells

  280. Cohen AR, **Rooney C**. Osteolysis circumscripta evanescans. Pediatr Neurosurg. 1996 Sep; 25(3):156-8; discussion 158-9. PMID: [9144716](//www.ncbi.nlm.nih.gov/pubmed/9144716).

Citations:  Fields:

Neu NeurosurgeryPed Pediatrics

Translation:Humans

  281. [Heslop HE](https://profiles.viictr.org/profile/269811), Ng CY, Li C, Smith CA, Loftin SK, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK, **Rooney CM**. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996 May; 2(5):551-5. PMID: [8616714](//www.ncbi.nlm.nih.gov/pubmed/8616714).

Citations:
[195](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8616714/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCells

  282. Cela ME, Holladay MS, **Rooney CM** , Richardson S, Alexander B, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. Bone Marrow Transplant. 1996 Feb; 17(2):243-7. PMID: [8640174](//www.ncbi.nlm.nih.gov/pubmed/8640174).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8640174/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  283. [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Rill DR, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK. Use of gene marking in bone marrow transplantation. Cancer Detect Prev. 1996; 20(2):108-13. PMID: [8706035](//www.ncbi.nlm.nih.gov/pubmed/8706035).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8706035/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  284. [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Brenner MK. Gene-marking and haemopoietic stem-cell transplantation. Blood Rev. 1995 Dec; 9(4):220-5. PMID: [8839397](//www.ncbi.nlm.nih.gov/pubmed/8839397).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8839397/citedby/) Fields:

Hem Hematology

Translation:Humans

  285. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, **Rooney CM** , Arrand JR. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology. 1995 Apr 20; 208(2):521-30. PMID: [7538250](//www.ncbi.nlm.nih.gov/pubmed/7538250).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7538250/citedby/) Fields:

Vir Virology

Translation:HumansCells

  286. Smith CA, Ng CY, [Heslop HE](https://profiles.viictr.org/profile/269811), Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, **Rooney CM**. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother. 1995 Apr; 4(2):73-9. PMID: [7633844](//www.ncbi.nlm.nih.gov/pubmed/7633844).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7633844/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  287. **Rooney CM** , Smith CA, Ng CY, Loftin S, Li C, [Krance RA](https://profiles.viictr.org/profile/268199), Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811). Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995 Jan 07; 345(8941):9-13. PMID: [7799740](//www.ncbi.nlm.nih.gov/pubmed/7799740).

Citations:
[259](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7799740/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  288. **Rooney CM** , Loftin SK, Holladay MS, Brenner MK, [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811). Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol. 1995 Jan; 89(1):98-103. PMID: [7833284](//www.ncbi.nlm.nih.gov/pubmed/7833284).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7833284/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  289. [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, **Rooney CM**. Donor T cells to treat EBV-associated lymphoma. N Engl J Med. 1994 Sep 08; 331(10):679-80. PMID: [8052285](//www.ncbi.nlm.nih.gov/pubmed/8052285).

Citations:
[62](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8052285/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  290. Stewart JP, Behm FG, Arrand JR, **Rooney CM**. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology. 1994 May 01; 200(2):724-32. PMID: [8178456](//www.ncbi.nlm.nih.gov/pubmed/8178456).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8178456/citedby/) Fields:

Vir Virology

Translation:HumansCells

  291. [Heslop HE](https://profiles.viictr.org/profile/269811), Li C, [Krance RA](https://profiles.viictr.org/profile/268199), Loftin SK, **Rooney CM**. Epstein-Barr infection after bone marrow transplantation. Blood. 1994 Mar 15; 83(6):1706-8. PMID: [8123864](//www.ncbi.nlm.nih.gov/pubmed/8123864).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8123864/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  292. [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, **Rooney C** , [Krance RA](https://profiles.viictr.org/profile/268199), Roberts WM, Rochester R, Smith CA, Turner V, Sixbey J, Moen R, et al. Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther. 1994 Mar; 5(3):381-97. PMID: [8018749](//www.ncbi.nlm.nih.gov/pubmed/8018749).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8018749/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  293. Brenner MK, [Heslop HE](https://profiles.viictr.org/profile/269811), Rill D, Li C, Nilson T, Roberts M, Smith C, [Krance R](https://profiles.viictr.org/profile/268199), **Rooney C**. Gene transfer and bone marrow transplantation. Cold Spring Harb Symp Quant Biol. 1994; 59:691-7. PMID: [7587132](//www.ncbi.nlm.nih.gov/pubmed/7587132).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7587132/citedby/) Fields:

Bio Biology

Translation:HumansCells

  294. Brenner MK, Rill DR, [Heslop HE](https://profiles.viictr.org/profile/269811), **Rooney CM** , Roberts WM, Li C, Nilson T, [Krance RA](https://profiles.viictr.org/profile/268199). Gene marking after bone marrow transplantation. Eur J Cancer. 1994; 30A(8):1171-6. PMID: [7654451](//www.ncbi.nlm.nih.gov/pubmed/7654451).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7654451/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  295. Williams LL, **Rooney CM** , Conley ME, Brenner MK, [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811). Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet. 1993 Sep 04; 342(8871):587-8. PMID: [8102723](//www.ncbi.nlm.nih.gov/pubmed/8102723).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8102723/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  296. Stewart JP, **Rooney CM**. The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses. Virology. 1992 Dec; 191(2):773-82. PMID: [1333123](//www.ncbi.nlm.nih.gov/pubmed/1333123).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1333123/citedby/) Fields:

Vir Virology

Translation:HumansCells

  297. **Rooney CM** , Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. J Virol. 1992 Jan; 66(1):496-504. PMID: [1309259](//www.ncbi.nlm.nih.gov/pubmed/1309259); PMCID: [PMC238310](//www.ncbi.nlm.nih.gov/pmc/articles/PMC238310).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1309259/citedby/) Fields:

Vir Virology

Translation:HumansCells

  298. **Rooney CM** , Kaye EM, Scott RM, Klucznik RP, Rosman NP. Modified encephaloduroarteriosynangiosis as a surgical treatment of childhood moyamoya disease: report of five cases. J Child Neurol. 1991 Jan; 6(1):24-31. PMID: [2002197](//www.ncbi.nlm.nih.gov/pubmed/2002197).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2002197/citedby/) Fields:

Neu NeurologyPed Pediatrics

Translation:Humans

  299. Buschle M, Brenner MK, Chen IS, Drexler HG, Gignac SM, **Rooney CM**. Transfection and gene expression in normal and malignant primary B lymphocytes. J Immunol Methods. 1990 Oct 04; 133(1):77-85. PMID: [1698880](//www.ncbi.nlm.nih.gov/pubmed/1698880).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1698880/citedby/) Fields:

All Allergy and ImmunologyCli Clinical Laboratory Techniques

Translation:HumansCells

  300. Packham G, Economou A, **Rooney CM** , Rowe DT, Farrell PJ. Structure and function of the Epstein-Barr virus BZLF1 protein. J Virol. 1990 May; 64(5):2110-6. PMID: [2157874](//www.ncbi.nlm.nih.gov/pubmed/2157874); PMCID: [PMC249368](//www.ncbi.nlm.nih.gov/pmc/articles/PMC249368).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2157874/citedby/) Fields:

Vir Virology

Translation:AnimalsCells

  301. **Rooney CM** , Rowe DT, Ragot T, Farrell PJ. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol. 1989 Jul; 63(7):3109-16. PMID: [2542618](//www.ncbi.nlm.nih.gov/pubmed/2542618); PMCID: [PMC250868](//www.ncbi.nlm.nih.gov/pmc/articles/PMC250868).

Citations:
[119](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2542618/citedby/) Fields:

Vir Virology

Translation:HumansCells

  302. **Rooney C** , Howe JG, Speck SH, Miller G. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J Virol. 1989 Apr; 63(4):1531-9. PMID: [2538644](//www.ncbi.nlm.nih.gov/pubmed/2538644); PMCID: [PMC248385](//www.ncbi.nlm.nih.gov/pmc/articles/PMC248385).

Citations:
[64](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2538644/citedby/) Fields:

Vir Virology

Translation:HumansCells

  303. Taylor N, Countryman J, **Rooney C** , Katz D, Miller G. Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses. J Virol. 1989 Apr; 63(4):1721-8. PMID: [2538652](//www.ncbi.nlm.nih.gov/pubmed/2538652); PMCID: [PMC248431](//www.ncbi.nlm.nih.gov/pmc/articles/PMC248431).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2538652/citedby/) Fields:

Vir Virology

Translation:Cells

  304. Farrell PJ, Rowe DT, **Rooney CM** , Kouzarides T. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 1989 Jan; 8(1):127-32. PMID: [2540954](//www.ncbi.nlm.nih.gov/pubmed/2540954); PMCID: [PMC400780](//www.ncbi.nlm.nih.gov/pmc/articles/PMC400780).

Citations:
[191](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2540954/citedby/) Fields:

Bio BiotechnologyMol Molecular Biology

Translation:Cells

  305. **Rooney C** , Taylor N, Countryman J, Jenson H, Kolman J, Miller G. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9801-5. PMID: [2849118](//www.ncbi.nlm.nih.gov/pubmed/2849118); PMCID: [PMC282869](//www.ncbi.nlm.nih.gov/pmc/articles/PMC282869).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2849118/citedby/) Fields:

Sci Science

Translation:Cells

  306. Young LS, Yao QY, **Rooney CM** , Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol. 1987 Nov; 68 ( Pt 11):2853-62. PMID: [2824665](//www.ncbi.nlm.nih.gov/pubmed/2824665).

Citations:
[53](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2824665/citedby/) Fields:

Vir Virology

Translation:HumansCells

  307. Miller G, Grogan E, Rowe D, **Rooney C** , Heston L, Eastman R, Andiman W, Niederman J, Lenoir G, Henle W, et al. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis. 1987 Jul; 156(1):26-35. PMID: [3036961](//www.ncbi.nlm.nih.gov/pubmed/3036961).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3036961/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCells

  308. **Rooney CM** , Edwards CF, Lenoir GM, Rupani H, Rickinson AB. Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: relationship to the BL-cell surface phenotype. Cell Immunol. 1986 Oct 01; 102(1):99-112. PMID: [3026651](//www.ncbi.nlm.nih.gov/pubmed/3026651).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3026651/citedby/) Fields:

All Allergy and ImmunologyCel Cell Biology

Translation:HumansCells

  309. **Rooney CM** , Gregory CD, Rowe M, Finerty S, Edwards C, Rupani H, Rickinson AB. Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. J Natl Cancer Inst. 1986 Sep; 77(3):681-7. PMID: [2943927](//www.ncbi.nlm.nih.gov/pubmed/2943927).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2943927/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  310. Rowe M, **Rooney CM** , Edwards CF, Lenoir GM, Rickinson AB. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma. Int J Cancer. 1986 Mar 15; 37(3):367-73. PMID: [3005176](//www.ncbi.nlm.nih.gov/pubmed/3005176).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3005176/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  311. **Rooney CM** , Wimperis JZ, Brenner MK, Patterson J, Hoffbrand AV, Prentice HG. Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol. 1986 Mar; 62(3):413-20. PMID: [3513817](//www.ncbi.nlm.nih.gov/pubmed/3513817).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3513817/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  312. **Rooney CM** , Rowe M, Wallace LE, Rickinson AB. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature. 1985 Oct 17-23; 317(6038):629-31. PMID: [2997615](//www.ncbi.nlm.nih.gov/pubmed/2997615).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2997615/citedby/) Fields:

Sci Science

Translation:HumansCells

  313. Rowe M, **Rooney CM** , Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer. 1985 Apr 15; 35(4):435-41. PMID: [2985508](//www.ncbi.nlm.nih.gov/pubmed/2985508).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2985508/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  314. **Rooney CM** , Rowe M, Rickinson AB, Lenoir GM, Moss DM, Epstein MA. Endemic and sporadic cases of Epstein-Barr virus-positive Burkitt's lymphoma: immunological characterization of derived cell lines. Haematol Blood Transfus. 1985; 29:308-11. PMID: [2993123](//www.ncbi.nlm.nih.gov/pubmed/2993123).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  315. **Rooney CM** , Rickinson AB, Moss DJ, Lenoir GM, Epstein MA. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. IARC Sci Publ. 1985; (60):249-64. PMID: [2998992](//www.ncbi.nlm.nih.gov/pubmed/2998992).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2998992/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  316. **Rooney CM** , Rickinson AB, Moss DJ, Lenoir GM, Epstein MA. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro. Int J Cancer. 1984 Sep 15; 34(3):339-48. PMID: [6090321](//www.ncbi.nlm.nih.gov/pubmed/6090321).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6090321/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  317. **Rooney CM** , Munro AJ. NK cells can recognize asialylated autologous lymphocytes and ABO-mismatched lymphocytes. Immunology. 1984 Jan; 51(1):193-9. PMID: [6418639](//www.ncbi.nlm.nih.gov/pubmed/6418639); PMCID: [PMC1454391](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1454391).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6418639/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 294 publications over 31 distinct years, with a maximum of
21 publications in
2014](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|21&cht=bvs&chd=t:29,24,33,14,43,14,24,29,62,57,67,57,67,67,43,52,76,86,67,48,100,57,24,62,48,24,14,29,24,33,29&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 6  
1995| 5  
1996| 7  
1997| 3  
1998| 9  
1999| 3  
2000| 5  
2001| 6  
2002| 13  
2003| 12  
2004| 14  
2005| 12  
2006| 14  
2007| 14  
2008| 9  
2009| 11  
2010| 16  
2011| 18  
2012| 14  
2013| 10  
2014| 21  
2015| 12  
2016| 5  
2017| 13  
2018| 10  
2019| 5  
2020| 3  
2021| 6  
2022| 5  
2023| 7  
2024| 6  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

ROONEY's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (735)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Herpesvirus 4, Human](https://profiles.viictr.org/profile/263895)
  * [T-Lymphocytes, Cytotoxic](https://profiles.viictr.org/profile/242982)
  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [T-Lymphocytes](https://profiles.viictr.org/profile/263702)
  * [Epstein-Barr Virus Infections](https://profiles.viictr.org/profile/260828)

[Explore](https://profiles.viictr.org/profile/268355/198)

_

Co-Authors (107)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [OMER, BILAL](https://profiles.viictr.org/profile/3009902)

[Explore](https://profiles.viictr.org/profile/268355/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [CHAMPLIN, RICHARD E](https://profiles.viictr.org/profile/12582508)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)

[Explore](https://profiles.viictr.org/profile/268355/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [GRILLEY, BAMBI](https://profiles.viictr.org/profile/266987)
  * [KRUEGER, RACHEL](https://profiles.viictr.org/profile/40483019)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)
  * [MENDOZA, ALEX](https://profiles.viictr.org/profile/5236831)
  * [YASSINE, KHALED](https://profiles.viictr.org/profile/3010521)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [AHMED, NABIL](https://profiles.viictr.org/profile/268944)
  * [DAVIS, ELIZABETH](https://profiles.viictr.org/profile/269827)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [KRANCE, ROBERT](https://profiles.viictr.org/profile/268199)
  * [YASSINE, KHALED](https://profiles.viictr.org/profile/3010521)

_

